<SEC-DOCUMENT>0001104659-23-045710.txt : 20230417
<SEC-HEADER>0001104659-23-045710.hdr.sgml : 20230417
<ACCEPTANCE-DATETIME>20230414173126
ACCESSION NUMBER:		0001104659-23-045710
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230414
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230417
DATE AS OF CHANGE:		20230414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		23822193

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		203 787 7888

	MAIL ADDRESS:	
		STREET 1:		4 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2312629d2_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:PRPO="http://precipiodx.com/20230414">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_PRPO_precipiodx.com_20230414 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230414_20230414 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001043961 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityCentralIndexKey">0001043961</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prpo-20230414.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-04-14to2023-04-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001043961</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-14</xbrli:startDate>
        <xbrli:endDate>2023-04-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span><b>WASHINGTON, D. C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20230414__20230414_z0PRSfEUQxsb"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br />
PURSUANT TO SECTION 13 OR 15(d) OF THE<br />
SECURITIES EXCHANGE ACT OF 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<span id="xdx_90F_edei--DocumentPeriodEndDate_c20230414__20230414_zPjAipqk2cYj"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 14, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20230414__20230414_zkzVQEzh2ufe" style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityRegistrantName">PRECIPIO,
INC.</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif"><br />
</span></b><span style="font-family: Times New Roman, Times, Serif"><i>(Exact Name of Registrant as Specified in Its Charter)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 32%"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20230414__20230414_z9tMaVBGsdv5"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%; font-size: 10pt">&#160;</td>
    <td style="text-align: center; width: 32%"><b><span id="xdx_90A_edei--EntityFileNumber_c20230414__20230414_zxBd1xnLwoQ3"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityFileNumber">001-36439</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 2%; font-size: 10pt">&#160;</td>
    <td style="text-align: center; width: 32%"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20230414__20230414_zRCda9iyD6Fl"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityTaxIdentificationNumber">91-1789357</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><i>(State of Incorporation)</i></span></td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><i>(Commission File Number)</i></span></td>
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><i>(I.R.S. Employer Identification No.)</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20230414__20230414_zHodcSFqnk34"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityAddressAddressLine1">4 Science Park</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressCityOrTown_c20230414__20230414_zNvDZe0z2ahe"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityAddressCityOrTown">New Haven</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20230414__20230414_z2fniptDRBSd"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityAddressStateOrProvince">CT</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20230414__20230414_zjGkorKeEUkk"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:EntityAddressPostalZipCode">06511</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of principal executive offices) (Zip
Code)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_900_edei--CityAreaCode_c20230414__20230414_z1spNZgDkaJb"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:CityAreaCode">203</ix:nonNumeric></span>) <span id="xdx_90D_edei--LocalPhoneNumber_c20230414__20230414_z4abOFwxeFzb"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:LocalPhoneNumber">787-7888</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Registrant's telephone number, including area
code)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span><b><br />
</b><i><i>(Former name, former address and former fiscal year, if changed
since last report date)</i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20230414__20230414_zw3SWCCoFCQb"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90D_edei--SolicitingMaterial_c20230414__20230414_zkIj3I9sUBoi"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20230414__20230414_zIiYeLpwkvOb"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20230414__20230414_zXo9LO3qmoGb"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; width: 36%">&#160;</td>
    <td style="padding: 1.5pt; width: 28%">&#160;</td>
    <td style="padding: 1.5pt; width: 36%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: black 1pt solid; padding: 1.5pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Ticker symbol(s)</span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which<br />
registered</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--Security12bTitle_c20230414__20230414_zIK2CToiaYbd"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:Security12bTitle">Common Stock, $0.01 par value per share</ix:nonNumeric></span></span></td>
    <td style="border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--TradingSymbol_c20230414__20230414_zjReqYLKwue6"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" name="dei:TradingSymbol">PRPO</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--SecurityExchangeName_c20230414__20230414_zzTyFz88OMCe"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 23pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 23pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35pt"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company </span><span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20230414__20230414_zW8QlQ7o6DH"><ix:nonNumeric contextRef="From2023-04-14to2023-04-14" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 0.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 0.35pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 0.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 0.35pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 0.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into Material Definitive Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>At The Market Offering Agreement </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
April 14, 2023, Precipio, Inc. (the &#8220;Company&#8221;) entered into a Sales Agreement with&#160;</span>A.G.P./Alliance Global Partners
(&#8220;A.G.P.&#8221;), pursuant to which the Company may offer and sell from time to time shares (the &#8220;Shares&#8221;) of its common
stock, par value $0.01 per share (the &#8220;Common Stock&#8221;) to or through&#160;A.G.P., as sales agent (the &#8220;Sales Agreement&#8221;),
in an &#8220;at the market offering&#8221; (as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended) of the Shares (the
&#8220;ATM Offering&#8221;).&#160; A.G.P. will be entitled to a commission at a fixed rate of 3.0% of the gross proceeds from each sale
of Shares pursuant to the Sales Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Due
to the offering limitations applicable to us under General Instruction I.B.6. of Form S-3, so long as our public float remains below $75,000,000,
we may not sell shares with a value greater than one-third of our public float in any 12-month period. Accordingly, the Company has filed
a prospectus to its registration statement on Form S-3 (File No. [&#9;]) offering shares of common stock having an aggregate gross sales
price of up to $5,800,000 pursuant to the Sales Agreement. If our public float increases such that we may sell additional amounts under
the Sales Agreement, we will be required to file another prospectus supplement prior to making additional sales. </span>The $5,800,000
of Common Stock that may be offered, issued and sold under the ATM Prospectus is included in the $50,000,000 of securities that may be
offered, issued and sold by us under the Base Prospectus. No Shares may be sold under the Prospectus until the Registration Statement
has been declared effective by the United States Securities and Exchange Commission (the &#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 48.95pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Sales Agreement, Shares may be sold by any method permitted by law deemed to be an &#8220;at the market offering.&#8221; A.G.P. will
also be able to sell shares of Common Stock by any other method permitted by law, including in negotiated transactions with the Company&#8217;s
prior written consent. Upon delivery of a placement notice and subject to the terms and conditions of the Sales Agreement, A.G.P. is required
to use its commercially reasonable efforts consistent with its normal trading and sales practices, applicable state and federal law, rules
and regulations, and the rules of The Nasdaq Capital Market to sell the Shares from time to time based upon the Company&#8217;s instructions,
including any price, time or size limits specified by the Company. A.G.P. is not under any obligation to purchase any of the Shares on
a principal basis pursuant to the Sales Agreement, except as otherwise agreed by A.G.P. and the Company in writing and expressly set forth
in a placement notice. A.G.P.&#8217;s obligations to sell the Shares under the Sales Agreement are subject to satisfaction of certain
conditions, including customary closing conditions. The Company is not obligated to make any sales of Shares under the Sales Agreement
and any determination by the Company to do so will be dependent, among other things, on market conditions and the Company&#8217;s capital
raising needs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The
Sales Agreement contains representations, warranties and covenants that are customary for transactions of this type. In addition, the
Company has provided A.G.P. with customary indemnification and contribution rights. The Company has also agreed to reimburse A.G.P. for
certain specified expenses, including the expenses of counsel to A.G.P. The offering of the Shares pursuant to the Sales Agreement will
terminate upon the termination of the Sales Agreement by A.G.P. or the Company, as permitted therein.</span> This Current Report on 8-K
(this &#8220;Report&#8221;) shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of
the Shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Sales Agreement is qualified in its entirety by reference to the full text of the Sales Agreement, which is attached as an exhibit
to the Registration Statement as Exhibit 1.1 and is incorporated herein in its entirety by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Current Report on Form
8-K shall not constitute an offer to sell or the solicitation of an offer to buy any shares under the Sales Agreement, nor shall there
be any sale of such shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Forward-Looking Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that statements in this Current Report on Form 8-K are
not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities
Litigation Reform Act of 1995. The terms &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;project,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should&#8221; and &#8220;intend,&#8221;
and other words or phrases of similar import are intended to identify forward-looking statements. These forward-looking statements are
subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the
statements made. These statements are based on the Company&#8217;s current beliefs and expectations as to such future outcomes. For a
discussion of other risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements,
see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and other
reports filed with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking
statements as the statements in this current report on Form 8-K are valid only as of the date hereof and disclaims any obligation to update
this information, except as may be required by&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><a href="tm2312629d2_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif">1.1</span></a></td><td style="text-align: justify"><a href="tm2312629d2_ex1-1.htm" style="-sec-extract: exhibit">Sales Agreement, dated April 14, 2021, by and between Precipio,
Inc. and A.G.P./Alliance Global Partners.</a></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">104</td><td style="text-align: justify">Cover Page Interactive Data File (embedded within the Inline
XBRL document).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRECIPIO, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">s/ Ilan Danieli </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ilan Danieli</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#160;&#160;&#160;&#160;&#160;&#160;April 14, 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6La4bKrpLh4o4ZQwRb4uLUtyakdafPZJvabchhkBIzvlyhBiJDa11hQznZZHBEeumUg6hwCsymgt6R7rdJeBngTdtHSvj+vUHpuQZ9Mx0vFD+3juf2mKZgJyHsQzjCOQkkTPI9yLo9JTMVZdonFYVKFNCztSwRqe4HT4c1ZsM1W2fdEK2mkwC0VgO8gdiGcVwoKd6Ed8tZFkqglFfgdgwPZou5mEd1bCqsPZZdkD/HXwB39lJHA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2312629d2_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>PRECIPIO,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>COMMON
STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>SALES
AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">April 14, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A.G.P./Alliance Global Partners</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">590 Madison Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Precipio, Inc., a Delaware
corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), confirms its agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;) with A.G.P./Alliance
Global Partners (the &ldquo;<B><U>Sales Agent</U></B>&rdquo;), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Issuance and Sale of
Shares</U>. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set
forth herein, it may issue and sell to or through the Sales Agent shares of the Company&rsquo;s common stock, par value $0.01 per share
(the &ldquo;<B><U>Common Stock</U></B>&rdquo;), subject to the limitations set forth in <U>Section 3(b)</U> hereof. The issuance and sale
of shares of Common Stock to or through the Sales Agent will be effected pursuant to the Registration Statement (as defined below) filed
by the Company and which was declared effective under the Securities Act (as defined below) by the U.S. Securities and Exchange Commission
(the &ldquo;<B><U>Commission</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has prepared
and will file, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations
thereunder (collectively, the &ldquo;<B><U>Securities Act</U></B>&rdquo;), with the Commission, a shelf registration statement on
Form S-3, including a base prospectus, relating to certain securities, including the shares of Common Stock, to
be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in
accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder
(collectively, the &ldquo;<B><U>Exchange Act</U></B>&rdquo;). The Company has prepared a prospectus supplement specifically relating
to the offering of Common Stock pursuant to this Agreement (the &ldquo;<B><U>ATM Prospectus</U></B>&rdquo;). The Company will
furnish to the Sales Agent, for use by the Sales Agent, copies of the base prospectus included as part of such registration
statement at the time it became effective, as supplemented by the ATM Prospectus. Except where the context otherwise requires, such
registration statement, as amended at the time of such registration statement&rsquo;s effectiveness for purposes of Section 11 of
the Securities Act, including all documents filed as a part thereof or incorporated by reference therein, and including any
information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the
Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b) of the Securities Act, is
herein called the &ldquo;<B><U>Registration Statement</U></B>.&rdquo; The base prospectus, including all documents incorporated
therein by reference (to the extent such information has not been superseded or modified in accordance with Rule 412 under the
Securities Act (as qualified by Rule 430B(g) of the Securities Act)), and the ATM Prospectus, including all documents incorporated
therein by reference (to the extent such information has not been superseded or modified in accordance with Rule 412 under the
Securities Act (as qualified by Rule 430B(g) of the Securities Act)), each of which is included in the Registration Statement, as it
or they may be supplemented by any additional prospectus supplement, in the form in which such prospectus and/or ATM Prospectus have
most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any
 &ldquo;issuer free writing prospectus&rdquo; (&ldquo;<B><U>Issuer Free Writing Prospectus</U></B>&rdquo;), as defined in Rule 433 of
the Securities Act (&ldquo;<B><U>Rule 433</U></B>&rdquo;), relating to the Placement Shares (as defined below) that (i) is required
to be filed with the Commission by the Company or (ii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case in the form
filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s
records pursuant to Rule 433(g), is herein called the &ldquo;<B><U>Prospectus</U></B>.&rdquo; Any reference herein to the
Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents
incorporated by reference therein, and any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or
 &ldquo;supplement&rdquo; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the
filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. For purposes
of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be
deemed to include any copy filed with the Commission pursuant to either the Electronic Data Gathering Analysis and Retrieval System,
or if applicable, the Interactive Data Electronic Applications (collectively &ldquo;<B><U>EDGAR</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Placements</U>. Each
time that the Company wishes to issue and sell the Common Stock through the Sales Agent, as agent, hereunder (each, a &ldquo;<B><U>Placement</U></B>&rdquo;),
it will notify the Sales Agent by email notice (or other method mutually agreed to in writing by the parties) (a &ldquo;<B><U>Placement
Notice</U></B>&rdquo;) containing the parameters in accordance with which it desires the Common Stock to be sold, which shall at a minimum
include the number of shares of Common Stock to be issued (the &ldquo;<B><U>Placement Shares</U></B>&rdquo;), the time period during which
sales are requested to be made, any limitation on the number of shares of Common Stock that may be sold in any one Trading Day (as defined
in <U>Section 3</U>) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters
necessary is attached hereto as <B><U>Schedule 1</U></B>. The Placement Notice shall originate from any of the individuals from the Company
set forth on <B><U>Schedule 2</U></B> (with a copy to each of the other individuals from the Company listed on such schedule), and shall
be addressed to each of the individuals from the Sales Agent set forth on <B><U>Schedule 2</U></B>, as such <B><U>Schedule 2</U></B> may
be amended from time to time. The Placement Notice shall be effective upon receipt by the Sales Agent unless and until (i) in accordance
with the notice requirements set forth in <U>Section 4</U>, the Sales Agent declines to accept the terms contained therein for any reason,
in its sole discretion, (ii) the entire amount of the Placement Shares have been sold, (iii) in accordance with the notice requirements
set forth in <U>Section 4</U>, the Company suspends or terminates the Placement Notice, (iv) the Company issues a subsequent Placement
Notice with parameters superseding those on the earlier dated Placement Notice, or (v) the Agreement has been terminated under the provisions
of <U>Section 11</U>. The amount of any discount, commission or other compensation to be paid by the Company to the Sales Agent in connection
with the sale of the Placement Shares through the Sales Agent, as agent, shall be as set forth in <B><U>Schedule 3</U></B>. It is expressly
acknowledged and agreed that neither the Company nor the Sales Agent will have any obligation whatsoever with respect to a Placement or
any Placement Shares unless and until the Company delivers a Placement Notice to the Sales Agent and the Sales Agent does not decline
such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of
a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Sale of Placement Shares
by the Sales Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) Subject to the terms and
conditions set forth herein, upon the Company&rsquo;s issuance of a Placement Notice, and unless the sale of the Placement Shares described
therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, the Sales Agent, as agent
for the Company, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state
and federal laws, rules and regulations and the rules of The Nasdaq Capital Market (the &ldquo;<B><U>Exchange</U></B>&rdquo;), for the
period specified in the Placement Notice, to sell such Placement Shares up to the amount specified by the Company in, and otherwise in
accordance with, the terms of such Placement Notice. If acting as agent hereunder, the Sales Agent will provide written confirmation to
the Company (including by email correspondence to each of the individuals of the Company set forth on <B><U>Schedule 2</U></B>, if receipt
of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) no later
than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares
hereunder setting forth the number of Placement Shares sold on such day, the volume-weighted average price of the Placement Shares, the
compensation payable by the Company to the Sales Agent pursuant to <U>Section 2</U> with respect to such sales, and the Net Proceeds (as
defined below) payable to the Company, with an itemization of the deductions made by the Sales Agent (as set forth in <U>Section 5(a)</U>)
from the gross proceeds that it receives from such sales. Subject to the terms of the Placement Notice, the Sales Agent may sell Placement
Shares by any method permitted by law deemed to be an &ldquo;at the market&rdquo; offering as defined in Rule 415 under the Securities
Act, including without limitation sales made directly on the Exchange, on any other existing trading market for the Common Stock or to
or through a market maker. Subject to the terms of a Placement Notice, the Sales Agent may also sell Placement Shares by any other method
permitted by law, including but not limited to in negotiated transactions with the Company&rsquo;s prior written consent. The Company
acknowledges and agrees that (i) there can be no assurance that the Sales Agent will be successful in selling Placement Shares, (ii) the
Sales Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for
any reason other than a failure by the Sales Agent to use its commercially reasonable efforts consistent with its normal trading and sales
practices and applicable law and regulations to sell such Placement Shares as required under this Agreement and (iii) the Sales Agent
shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed
by the Sales Agent and the Company in writing and expressly set forth in a Placement Notice. For the purposes hereof, &ldquo;<B><U>Trading
Day</U></B>&rdquo; means any day on which the Company&rsquo;s Common Stock is purchased and sold on the principal market on which the
Common Stock is listed or quoted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Under no circumstances
shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares,
the aggregate number or gross sales proceeds of Placement Shares sold pursuant to this Agreement would exceed the lesser of: (i) the number
or dollar amount of shares of Common Stock registered pursuant to the Registration Statement pursuant to which the offering hereunder
is being made, (ii) the number of authorized but unissued and unreserved shares of Common Stock, (iii) the number or dollar amount of
shares of Common Stock permitted to be offered and sold by the Company under Form S-3 (including General Instruction I.B.6 of Form S-3,
if applicable), (iv) the number or dollar amount of shares of Common Stock authorized from time to time to be issued and sold under this
Agreement by the Company&rsquo;s Board of Directors, a duly authorized committee thereof or a duly authorized executive committee, and
notified to the Sales Agent in writing, or (v) the number or dollar amount of shares of Common Stock for which the Company has filed the
ATM Prospectus or other prospectus supplement specifically relating to the offering of the Placement Shares pursuant to this Agreement.
Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price
lower than the minimum price authorized from time to time by the Company&rsquo;s Board of Directors, a duly authorized committee thereof
or a duly authorized executive committee, and notified to the Sales Agent in writing. Notwithstanding anything to the contrary contained
herein, the parties hereto acknowledge and agree that compliance with the limitations set forth in this <U>Section 3(b)</U> on the number
or dollar amount of Placement Shares that may be issued and sold under this Agreement from time to time shall be the sole responsibility
of the Company, and that the Sales Agent shall have no obligation in connection with such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) During the term of this
Agreement, neither the Sales Agent nor any of its affiliates or subsidiaries shall engage in (i) any short sale of any security of the
Company or (ii) any sale of any security of the Company that the Sales Agent does not own or any sale that is consummated by the delivery
of a security of the Company borrowed by, or for the account of, the Sales Agent. During the term of this Agreement and notwithstanding
anything to the contrary herein, the Sales Agent agrees that in no event will the Sales Agent or its affiliates engage in any market making,
bidding, stabilization or other trading activity with regard to the Common Stock or related derivative securities if such activity would
be prohibited under Regulation M or other anti-manipulation rules under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Suspension of Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Company or the Sales
Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party
set forth on <B><U>Schedule 2</U></B>, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the
notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence
to each of the individuals of the other party set forth on <B><U>Schedule 2</U></B>), suspend any sale of Placement Shares for a period
of time (a &ldquo;<B><U>Suspension Period</U></B>&rdquo;); <I>provided</I>, <I>however</I>, that such suspension shall not affect or impair
either party&rsquo;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. Each of the
parties hereto agrees that no such notice under this <U>Section 4</U> shall be effective against the other unless it is made to one of
the individuals named on <B><U>Schedule 2</U></B> hereto, as such schedule may be amended from time to time. During a Suspension Period,
the Company shall not issue any Placement Notices and the Sales Agent shall not sell any Placement Shares hereunder. The party that issued
a suspension notice shall notify the other party in writing of the Trading Day on which the Suspension Period shall expire not later than
twenty-four (24) hours prior to such Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding any other
provision of this Agreement, during any period in which the Company is in possession of material non-public information, the Company and
the Sales Agent agree that (i) no sale of Placement Shares will take place, (ii) the Company shall not request the sale of any Placement
Shares, and (iii) the Sales Agent shall not be obligated to sell or offer to sell any Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Settlement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(a) Settlement of Placement
Shares</U>. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the
second (2<FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>) Trading Day (or such earlier day as is industry practice for regular-way
trading) following the respective Point of Sale (as defined below) (each, a &ldquo;<B><U>Settlement Date</U></B>&rdquo;). The amount of
proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &ldquo;<B><U>Net Proceeds</U></B>&rdquo;)
will be equal to the aggregate sales price received by the Sales Agent at which such Placement Shares were sold, after deduction for (i)
the Sales Agent&rsquo;s discount, commission or other compensation for such sales payable by the Company pursuant to <U>Section 2</U>
hereof, (ii) any other amounts due and payable by the Company to the Sales Agent hereunder pursuant to Section 7(g) (Expenses) hereof
and (iii) any transaction fees, trading expenses, execution fees or other fees imposed by any clearing organization or any governmental
or self-regulatory organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Delivery of Placement
Shares</U>. On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement
Shares being sold by crediting the Sales Agent&rsquo;s or its designee&rsquo;s account (provided the Sales Agent shall have given the
Company written notice of such designee at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through
its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto
which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, the Sales
Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement
Date. The Company agrees that if the Company, defaults in its obligation to deliver duly authorized Placement Shares on a Settlement Date,
through no fault of the Sales Agent, the Company agrees that in addition to and in no way limiting the rights and obligations set forth
in <U>Section 9(a)</U> (Indemnification and Contribution) hereto, the Company will (i) hold the Sales Agent, its directors, officers,
members, partners, employees and agents of the Sales Agent, each broker dealer affiliate of the Sales Agent, and each person, if any,
who (A) controls the Sales Agent within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (B) is controlled
by or is under common control with the Sales Agent (each, a &ldquo;<B><U>Sales Agent Affiliate</U></B>&rdquo;), and the Sales Agent&rsquo;s
clearing organization, harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred,
arising out of or in connection with such default by the Company or its transfer agent (if applicable) and (ii) pay to the Sales Agent
any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Representations and
Warranties of the Company</U>. The Company represents and warrants to, and agrees with, the Sales Agent that as of each Applicable Time
(as defined in <U>Section 22(a)</U>), unless such representation, warranty or agreement specifies a different time or times:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(a) Compliance with Registration
Requirements</U>. As of each Applicable Time other than the date of this Agreement, the Registration Statement and any Rule 462(b) Registration
Statement have been declared effective by the Commission under the Securities Act. The Company has complied to the Commission&rsquo;s
satisfaction with all requests of the Commission for additional or supplemental information related to the Registration Statement and
the Prospectus. No stop order suspending the effectiveness of the Registration Statement, or any Rule 462(b) Registration Statement is
in effect and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated
or threatened by the Commission. The Registration Statement and, assuming no act or omission on the part of the Sales Agent that would
make such statements untrue, the offer and sale of the Placement Shares as contemplated hereby meet the requirements of Rule 415 under
the Securities Act and comply in all material respects with said Rule. In the section entitled &ldquo;Plan of Distribution&rdquo; in the
ATM Prospectus, the Company has named A.G.P./Alliance Global Partners as an agent that the Company has engaged in connection with the
transactions contemplated by this Agreement. The Company was not and is not an &ldquo;ineligible issuer&rdquo; as defined in Rule 405
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>No Misstatement or
Omission</U>. The Registration Statement and any post-effective amendment thereto, at the time it became or becomes effective, complied
or will comply in all material respects with the Securities Act. The Prospectus, and any amendment or supplement thereto, on the date
of such Prospectus or amendment or supplement, complied or will comply in all material respects with the Securities Act. The Registration
Statement and any post-effective amendment thereto, at the time it became or becomes effective, did not and will not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading. The Prospectus, as amended or supplemented, as of its date, did not and, as of each Point of Sale and each Settlement
Date, will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in
the two immediately preceding sentences do not apply to statements in or omissions from the Registration Statement or any post-effective
amendment thereto, or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity with information
relating to the Sales Agent furnished to the Company in writing by the Sales Agent expressly for use therein. &ldquo;<B><U>Point of Sale</U></B>&rdquo;
means, for a Placement, the time at which an acquiror of Placement Shares entered into a contract, binding upon such acquiror, to acquire
such Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Offering Materials
Furnished to the Sales Agent</U>. Copies of the Registration Statement, the Prospectus, and all amendments or supplements thereto and
all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement, have been
delivered, or are publicly available through EDGAR, to the Sales Agent. Each Prospectus delivered to the Sales Agent for use in connection
with the sale of the Placement Shares pursuant to this Agreement will be identical to the version of such Prospectus filed with the Commission
via EDGAR, except to the extent permitted by Regulation S-T.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Distribution of Offering
Material By the Company</U>. The Company has not distributed and will not distribute, prior to the completion of the Sales Agent&rsquo;s
distribution of the Placement Shares, any offering material in connection with the offering and sale of the Placement Shares other than
the Prospectus or the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>The Sales Agreement</U>.
This Agreement has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal, and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as rights to indemnity hereunder may be limited by
federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting the rights of creditors generally, and subject to general principles of equity. The Company has full corporate
power and authority to enter into this Agreement and to authorize, issue and sell the Placement Shares as contemplated by this Agreement.
This Agreement conforms in all material respects to the descriptions thereof in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Authorization of the
Placement Shares</U>. The Placement Shares, when issued and paid for as contemplated herein, will be validly issued, fully paid and nonassessable,
will be issued in compliance with all applicable securities laws, and will be free of preemptive, registration or similar rights, and
will conform to the description of the Common Stock contained in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>No Applicable Registration
or Other Similar Rights</U>. There are no persons with registration or other similar rights to have any equity or debt securities registered
for sale under the Registration Statement or included in the offering contemplated by this Agreement, except for such rights as have been
duly waived or complied with. No person has the right to act as an underwriter or as a financial advisor to the Company in connection
with the offer and sale of the Placement Shares hereunder, whether as a result of the filing or effectiveness of the Registration Statement
or the sale of the Placement Shares as contemplated hereby or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>No Material Adverse
Change</U>. Except as otherwise disclosed in the Prospectus, subsequent to the respective dates as of which information is given in the
Prospectus: (i) there has been no material adverse change in the business, properties, prospects, operations, condition (financial or
otherwise) or results of operations of the Company and its subsidiaries, taken as a whole (any such change is called a &ldquo;<B><U>Material
Adverse Change</U></B>&rdquo;), or any development involving a prospective material adverse change, which, individually or in the aggregate,
has had or would reasonably be expected to result in a Material Adverse Change; (ii) the Company and its subsidiaries, considered as one
entity, have not incurred any material liability or obligation, indirect, direct or contingent, not in the ordinary course of business
nor entered into any material transaction or agreement not in the ordinary course of business; (iii) there has been no dividend or distribution
of any kind declared, paid or made by the Company; (iv) no executive officer or director of the Company has resigned from any position
with the Company; and (v) there has not been any Material Adverse Change in the Company&rsquo;s long-term or short-term debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Independent Accountants</U>.
To the knowledge of the Company, Marcum LLP, whose reports are filed with the Commission and included or incorporated by reference in
the Registration Statement and the Prospectus, is an independent registered public accounting firm as required by the Securities Act and
the Public Company Accounting Oversight Board. Marcum LLP has not, during the periods covered by the financial statements included or
incorporated by reference in the Registration Statement and the Prospectus, provided to the Company any non-audit services, as such term
is used in Section 10A(g) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Financial Statements</U>.
The financial statements filed with the Commission as a part of the Registration Statement and included in the Prospectus, together with
the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and its
subsidiaries as of and at the dates indicated and the results of their operations and cash flows for the periods specified. Such financial
statements and supporting schedules have been prepared in conformity with U.S. generally accepted accounting principles (&ldquo;<B><U>GAAP</U></B>&rdquo;)
applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto. No other
financial statements or supporting schedules are required to be included in or incorporated in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Forward-Looking Statements.
</U>No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained
in the Registration Statement or the Prospectus has been made or reaffirmed by the Company without a reasonable basis or has been disclosed
by the Company other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(l) Statistical and Marketing-Related
Data</U>. The statistical and market-related data included in each of the Registration Statement and the Prospectus are based on or derived
from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the Company&rsquo;s good faith
estimates that are made on the basis of data derived from such sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>XBRL</U>. The interactive
data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the
information called for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Incorporation and Good
Standing of the Company and its Subsidiaries</U>. The Company is a corporation duly incorporated and validly existing under the laws of
the State of Delaware. The Company has requisite corporate power to carry on its business as described in the Prospectus. The Company
is duly qualified to transact business and is in good standing in all jurisdictions in which the conduct of its business requires such
qualification; except where the failure to be so qualified or to be in good standing would not result in a Material Adverse Change. The
Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed
in Exhibit 21.1 to the Company&rsquo;s Annual Report on Form 10-K for the most recently ended fiscal year and other than (i) those subsidiaries
not required to be listed on Exhibit 21.1 by Item 601 of Regulation S-K under the Exchange Act, (ii) those subsidiaries formed since the
last day of the most recently ended fiscal year, and (iii) as disclosed in the Registration Statement and the Prospectus. Each subsidiary
is a corporation or limited liability company duly incorporated or formed and validly existing under the laws of the jurisdiction of its
incorporation or formation and is in good standing under such laws. Each of the subsidiaries has requisite corporate power to carry on
its business as described in the Prospectus. Each of the subsidiaries is duly qualified to transact business and is in good standing in
all jurisdictions in which the conduct of its business requires such qualification; except where the failure to be so qualified or to
be in good standing would not result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Capital Stock Matters</U>.
All issued and outstanding shares of Common Stock of the Company issued prior to the transactions contemplated by this Agreement have
been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission with respect
thereto, and are not subject to personal liability by reason of being such holders; and none of such securities were issued in violation
of the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized
shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration Statement and
the Prospectus. The offers and sales of the outstanding shares of Common Stock were at all relevant times either registered under the
Securities Act and the applicable state securities or &ldquo;blue sky&rdquo; laws or, based in part on the representations and warranties
of the purchasers of such shares, exempt from such registration requirements. The description of the Company&rsquo;s stock option, stock
bonus and other stock plans or arrangements, and the options or other rights granted thereunder, as described in the Registration Statement
and the Prospectus, accurately and fairly present, in all material respects, the information required to be shown with respect to such
plans, arrangements, options and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>Non-Contravention of
Existing Instruments; No Further Authorizations or Approvals Required</U>. The Company&rsquo;s execution, delivery and performance of
this Agreement and consummation of the transactions contemplated hereby or by the Registration Statement and the Prospectus (including
the issuance and sale of the Placement Shares and the use of the proceeds from the sale of the Placement Shares as described in the Prospectus
under the caption &ldquo;Use of Proceeds&rdquo;) will not (A) result in a material breach or violation of any of the terms and provisions
of, or constitute a default under, any law, order, rule or regulation to which the Company or any subsidiary is subject (including, without
limitation, those promulgated by the Food and Drug Administration of the U.S. Department of Health and Human Services (the &ldquo;FDA&rdquo;)
or by any foreign, federal, state or local regulatory authority performing functions similar to those performed by the FDA), or by which
any property or asset of the Company or any subsidiary is bound or affected, (B) conflict with, result in any violation or breach of,
or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any right
of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) (a &ldquo;<B><U>Default Acceleration
Event</U></B>&rdquo;) of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other instrument (&ldquo;<B><U>Contract</U></B>&rdquo;)
or obligation or other understanding to which the Company or any subsidiary is a party or by which any property or asset of the Company
or any subsidiary is bound or affected, except to the extent that such conflict, default, or Default Acceleration Event is not reasonably
likely to result in a Material Adverse Change, or (C) result in a breach or violation of any of the terms and provisions of, or constitute
a default under, the Company&rsquo;s certificate of incorporation (as the same may be amended or restated from time to time) or bylaws
(as the same may be amended or restated from time to time). Neither the Company nor any of its subsidiaries is in violation, breach or
default under its certificate of incorporation (as the same may be amended or restated from time to time), bylaws (as the same may be
amended or restated from time to time) or other equivalent organizational or governing documents. Neither the Company nor any its subsidiaries
nor, to its knowledge, any other party is in violation, breach or default of any Contract that has resulted in or could reasonably be
expected to result in a Material Adverse Change. Each approval, consent, order, authorization, designation, declaration or filing by or
with any regulatory, administrative or other governmental body necessary in connection with the execution and delivery by the Company
of this Agreement and the performance of the Company of the transactions herein contemplated has been obtained or made and is in full
force and effect, except (i) with respect to any Applicable Time at which the Sales Agent would not be able to rely on Rule 5110(b)(7)(C)(i)
of the Financial Industry Regulatory Authority, Inc. (&ldquo;<B><U>FINRA</U></B>&rdquo;), such additional steps as may be required by
FINRA, (ii) filings with the Commission required under the Securities Act or the Exchange Act, or filings or notice with the Exchange
pursuant to the rules and regulations of the Exchange, in each case that are contemplated by this Agreement to be made after the date
of this Agreement, and (iii) such additional steps as may be necessary to qualify the Common Stock for sale by the Sales Agent under state
securities or Blue Sky laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>No Material Actions
or Proceedings</U>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding pending
or, to the Company&rsquo;s knowledge, threatened against, or involving the Company or, to the Company&rsquo;s knowledge, any executive
officer or director of the Company including any proceeding before the FDA or comparable federal, state, local or foreign governmental
bodies (it being understood that the interaction between the Company and the FDA and such comparable governmental bodies relating to the
clinical development and product approval process shall not be deemed proceedings for purposes of this representation), which is required
to be disclosed and has not been disclosed in the Registration Statement or the Prospectus, except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Labor Disputes</U>.
There is not pending or, to the knowledge of the Company, threatened, any action, suit or proceeding to which the Company or any of its
subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries is the subject before or by any court
or governmental agency, authority or body, or any arbitrator or mediator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Compliance with Certain
Applicable Laws. </U>The Company: (A) is and at all times has been in compliance with all statutes, rules, or regulations applicable to
the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer
for sale, storage, import, export or disposal of any product manufactured or distributed by the Company (&ldquo;<B><U>Applicable Laws</U></B>&rdquo;),
except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (B) has not received
any warning letter, untitled letter or other correspondence or notice from any governmental authority alleging or asserting noncompliance
with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto
required by any such Applicable Laws (&ldquo;<B><U>Authorizations</U></B>&rdquo;); (C) possesses all material Authorizations and such
Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations; (D) has
not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any
governmental authority or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations
and has no knowledge that any such governmental authority or third party is considering any such claim, litigation, arbitration, action,
suit, investigation or proceeding; (E) has not received notice that any governmental authority has taken, is taking or intends to take
action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority is considering
such action; and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records,
claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents,
forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or
were corrected or supplemented by a subsequent submission).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>Tax Law Compliance</U>.
Each of the Company and its subsidiaries has (a) filed all foreign, federal, state and local tax returns (as hereinafter defined) required
to be filed with taxing authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof and (b) paid
all taxes (as hereinafter defined) shown as due and payable on such returns that were filed and has paid all taxes imposed on or assessed
against the Company or such respective subsidiary. The provisions for taxes payable, if any, shown on the financial statements included
or incorporated by reference in the Registration Statement and the Prospectus are sufficient for all accrued and unpaid taxes, whether
or not disputed, and for all periods to and including the dates of such consolidated financial statements. Other than as disclosed in
the Registration Statement and the Prospectus, no material issues have been raised (and are currently pending) by any taxing authority
in connection with any of the returns or taxes asserted as due from the Company or its subsidiaries, and no waivers of statutes of limitation
with respect to the returns or collection of taxes have been given by or requested from the Company or its subsidiaries. There are no
tax liens against the assets, properties or business of the Company or any of its subsidiaries. The term &ldquo;<B><U>taxes</U></B>&rdquo;
mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise,
profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property,
windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatever, together with any interest and any
penalties, additions to tax, or additional amounts with respect thereto. The term &ldquo;<B><U>returns</U></B>&rdquo; means all returns,
declarations, reports, statements, and other documents required to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Company Not an &ldquo;Investment
Company</U>&rdquo;. The Company is not, and will not be, either after receipt of payment for the Placement Shares or after the application
of the proceeds therefrom as described under &ldquo;Use of Proceeds&rdquo; in the Registration Statement or the Prospectus, required to
register as an &ldquo;investment company&rdquo; under the Investment Company Act of 1940, as amended (the <B>&ldquo;<U>Investment Company
Act</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) <U>Insurance</U>. The
Company and each of its subsidiaries carries, or is entitled to the benefits of insurance in such amounts and covering such risks, which
the Company believes are adequate for the conduct of its business and the value of its properties and as is customary for companies engaged
in similar businesses in similar industries, and all such insurance is in full force and effect. Neither the Company nor any of its subsidiaries
has reason to believe that it will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to
obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at
a cost that would not result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) <U>No Price Stabilization
or Manipulation</U>. The Company has not taken, directly or indirectly (without giving any effect to the activities of the Sales Agent),
any action designed to or that might cause or result in stabilization or manipulation of the price of the Common Stock or of any &ldquo;reference
security&rdquo; (as defined in Rule 100 of Regulation M under the Exchange Act (&ldquo;<B><U>Regulation M</U></B>&rdquo;)) with respect
to the Common Stock, whether to facilitate the sale or resale of the Placement Shares or otherwise, and has taken no action which would
directly or indirectly violate Regulation M.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) <U>Related Party Transactions</U>.
There are no business relationships or related party transactions involving the Company or any other person required to be described in
the Registration Statement and the Prospectus that have not been described as required pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) <U>Exchange Act Compliance</U>.
The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Prospectus or any amendment or
supplement thereto, at the time they were or hereafter are filed with the Commission under the Exchange Act, complied and will comply
in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the Prospectus,
at each Point of Sale and each Settlement Date, will not contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) <U>Conformity of Issuer
Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements
of the Securities Act on the date of first use, and the Company has complied or will comply with any filing requirements applicable to
such Issuer Free Writing Prospectus pursuant to the Securities Act. Each Issuer Free Writing Prospectus, as of its issue date and at all
subsequent times through the completion of the public offer and sale of the Placement Shares, did not, does not and will not include any
information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus,
including any document incorporated by reference therein that has not been superseded or modified. The Company has not made any offer
relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus without the prior written consent of the Sales
Agent. The Company has retained in accordance with the Securities Act all Issuer Free Writing Prospectuses that were not required to be
filed pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>(aa) Compliance with Environmental
Laws</U>. The Company and its subsidiaries are in compliance with all foreign, federal, state and local rules, laws and regulations relating
to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment
which are applicable to their businesses (&ldquo;<B><U>Environmental Laws</U></B>&rdquo;), except where the failure to comply has not
had and would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Change. There has been no storage,
generation, transportation, handling, treatment, disposal, discharge, emission, or other release of any kind of toxic or other wastes
or other hazardous substances by, due to, or caused by the Company or any of its subsidiaries (or, to the Company&rsquo;s knowledge, any
other entity for whose acts or omissions the Company or any of its subsidiaries is or may otherwise be liable) upon any of the property
now or previously owned or leased by the Company or any of its subsidiaries, or upon any other property, in violation of any law, statute,
ordinance, rule, regulation, order, judgment, decree or permit or which would, under any law, statute, ordinance, rule (including rule
of common law), regulation, order, judgment, decree or permit, give rise to any liability, except for any violation or liability which
has not had and would not reasonably be expected to have, singularly or in the aggregate, a Material Adverse Change; and there has been
no disposal, discharge, emission or other release of any kind onto such property or into the environment surrounding such property of
any toxic or other wastes or other hazardous substances with respect to which the Company or any of its subsidiaries has knowledge. The
Company and its subsidiaries have reviewed the effect of Environmental Laws on their business and assets, in the course of which they
identified and evaluated associated costs and liabilities (including, without limitation, any capital or operating expenditures required
for clean-up, closure of properties or compliance with Environmental Laws or governmental permits issued thereunder, any related constraints
on operating activities and any potential liabilities to third parties). On the basis of such review, the Company has reasonably concluded
that such associated costs and liabilities would not have, singularly or in the aggregate, a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Intellectual Property</U>.
The Company owns or possess or has valid rights to use all patents, patent applications, trademarks, service marks, trade names, trademark
registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights (&ldquo;<B><U>Intellectual
Property Rights</U></B>&rdquo;) necessary for the conduct of the business of the Company and its subsidiaries as currently carried on
and as described in the Registration Statement and the Prospectus, except as would not be reasonably likely to result in a Material Adverse
Change. To the knowledge of the Company, no action or use by the Company or any of its subsidiaries necessary for the conduct of their
business as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to any infringement
of, or license or similar fees for, any Intellectual Property Rights of others, except where such action, use, license or fee is not reasonably
likely to result in a Material Adverse Change. Neither the Company nor any of its subsidiaries have received any notice alleging any such
infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as would not reasonably be expected to result,
individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company, there is no infringement, misappropriation
or violation by third parties of any of the Intellectual Property Rights owned by the Company or any of its subsidiaries; (B) there is
no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights of the Company
or any of its subsidiaries in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a
reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims in this <U>Section 6(bb)</U>,
reasonably be expected to result in a Material Adverse Change; (C) the Intellectual Property Rights owned by the Company or any of its
subsidiaries and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company have not been adjudged by
a court of competent jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or, to the Company&rsquo;s knowledge,
threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and
the Company is unaware of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate,
together with any other claims in this <U>Section 6(bb)</U>, reasonably be expected to result in a Material Adverse Change; (D) there
is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others that the Company or any of
its subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property Rights or other proprietary rights of others,
neither the Company nor any of its subsidiaries has received any written notice of such claim and the Company is unaware of any other
facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims
in this <U>Section 6(bb)</U>, reasonably be expected to result in a Material Adverse Change; and (E) to the Company&rsquo;s knowledge,
no employee of the Company or any of its subsidiaries is in or has ever been in violation in any material respect of any term of any employment
contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure
agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s
employment with the Company or any of its subsidiaries, or actions undertaken by the employee while employed with the Company or any of
its subsidiaries and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s
knowledge, all material technical information developed by and belonging to the Company or any of its subsidiaries which has not been
patented has been kept confidential. Neither the Company nor any of its subsidiaries is a party to or bound by any options, licenses or
agreements with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration
Statement and the Prospectus and are not described therein. The Registration Statement and the Prospectus contain in all material respects
the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company or its subsidiaries
has been obtained or is being used by the Company or any of its subsidiaries in violation of any contractual obligation binding on the
Company or any such subsidiary or, to the Company&rsquo;s knowledge, any of its or its subsidiaries&rsquo; officers, directors or employees,
or otherwise in violation of the rights of any persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Brokers</U>. Neither
the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than as contemplated
by this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or the Sales Agent for a brokerage
commission, finder&rsquo;s fee or like payment in connection with the offering and sale of the Placement Shares by the Sales Agent under
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No Outstanding Loans
or Other Indebtedness</U>. There are no outstanding loans, advances (except normal advances for business expenses in the ordinary course
of business) or guarantees or indebtedness by the Company or any of its subsidiaries to or for the benefit of any of the officers or directors
of the Company or executive officers of any of its subsidiaries to the extent such executive officers may be deemed executive officers
of the Company, or any of their respective family members, except as disclosed in the Registration Statement and the Prospectus. The Company
has not directly or indirectly extended or maintained credit, arranged for the extension of credit, or renewed an extension of credit,
in the form of a personal loan to or for any director or executive officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>No Reliance</U>. The
Company has not relied upon the Sales Agent or legal counsel for the Sales Agent for any legal, tax or accounting advice in connection
with the offering and sale of the Placement Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Broker-Dealer Status</U>.
Neither the Company nor any of its related entities (i) is required to register as a &ldquo;broker&rdquo; or &ldquo;dealer&rdquo; in accordance
with the provisions of the Exchange Act or (ii) directly or indirectly through one or more intermediaries, controls or is a &ldquo;person
associated with a member&rdquo; or &ldquo;associated person of a member&rdquo; (within the meaning of Article I of the NASD Manual administered
by FINRA). To the Company&rsquo;s knowledge, there are no affiliations or associations between any member of FINRA and any of the Company&rsquo;s
officers, directors or 5% or greater security holders, except as set forth in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>S-3 Eligibility</U>.
(i) At the time of filing the Registration Statement and (ii) at the time of the most recent amendment thereto for the purposes of complying
with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant
to Section 13 or 15(d) of the Exchange Act or form of prospectus), the Company met the then applicable requirements for use of Form S-3
under the Securities Act, including compliance with General Instruction I.B.1 or General Instruction I.B.6 of Form S-3, as applicable.
The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12
calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined
in General Instruction I.B.6 of Form S-3) with the Commission at least 12 calendar months previously reflecting its status as an entity
that is not a shell company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>FINRA Matters</U>.
All of the information provided to the Sales Agent or to counsel for the Sales Agent by the Company, its counsel, its officers and directors
and, to the Company&rsquo;s knowledge, the holders of any securities (debt or equity) or options to acquire any securities of the Company
in connection with the offering of the Placement Shares is true, complete, correct and compliant with FINRA&rsquo;s rules in all material
respects and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules or NASD Conduct Rules is
true, complete and correct in all material respects. Except as disclosed in the Registration Statement or the Prospectus, there is no
(i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class of the Company&rsquo;s securities or (iii) beneficial
owner of the Company&rsquo;s unregistered equity securities that were acquired during the 180-day period immediately preceding the date
of this Agreement that is an affiliate or associated person of a FINRA member participating in the offer, issuance and sale of the Placement
Shares as contemplated by this Agreement and the Registration Statement and the Prospectus (as determined in accordance with the rules
and regulations of FINRA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) <U>Compliance with Orders</U>.
Neither the Company nor any of its subsidiaries is in violation of any material judgment, decree, or order of any court, arbitrator or
other governmental authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Sarbanes&ndash;Oxley
Act</U>. There is and has been no failure on the part of the Company or any of the Company&rsquo;s directors or officers, in their capacities
as such, to comply in all material respects with any applicable provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations
promulgated in connection therewith (the &ldquo;<B><U>Sarbanes-Oxley Act</U></B>&rdquo;), including Section 402 related to loans and Sections
302 and 906 related to certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>Disclosure Controls
and Procedures</U>. Except as set forth in the Registration Statement and the Prospectus, the Company and its subsidiaries maintain systems
of &ldquo;internal control over financial reporting&rdquo; (as defined under Rules 13a-15 and 15d-15 under the Exchange Act) that comply
with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive
and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including, but not limited
to, internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s
general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s general
or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language included
or incorporated by references in the Registration Statement and the Prospectus fairly present the information called for in all material
respects and are prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto. Since the date of the latest
audited financial statements included in the Registration Statement and the Prospectus, there has been no change in the Company&rsquo;s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>ERISA</U>. The Company,
its subsidiaries and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security Act of 1974, as
amended, and the regulations and published interpretations thereunder (collectively, &ldquo;<B><U>ERISA</U></B>&rdquo;)) established or
maintained by the Company, its subsidiaries or any of their &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all
material respects with ERISA. &ldquo;<B><U>ERISA Affiliate</U></B>&rdquo; means, with respect to the Company and each of its subsidiaries,
any member of any group of organizations described in Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended,
and the regulations and published interpretations thereunder (the &ldquo;<B><U>Code</U></B>&rdquo;) of which the Company or any of its
subsidiaries is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is reasonably expected to occur with
respect to any &ldquo;employee benefit plan&rdquo; established or maintained by the Company, or any of its subsidiaries or any of their
ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company, any of its subsidiaries or any of their
ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo;
(as defined under ERISA). Neither the Company nor any of its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably
expects to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee
benefit plan&rdquo; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established or maintained
by the Company, any of its subsidiaries or any of their ERISA Affiliates that is intended to be qualified under Section 401(a) of the
Code is so qualified and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause
the loss of such qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Contracts and Agreements</U>.
The agreements and documents described in the Registration Statement and the Prospectus conform in all material respects to the descriptions
thereof contained therein and there are no agreements or other documents required by the Securities Act to be described in the Registration
Statement and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described
or filed. Each agreement or other instrument (however characterized or described) to which the Company or any of its subsidiaries is a
party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement and the Prospectus, or (ii)
is material to the Company&rsquo;s or its subsidiaries&rsquo; business, has been duly authorized and validly executed by the Company,
is in full force and effect in all material respects and is enforceable against the Company or any of its subsidiaries and, to the Company&rsquo;s
knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency,
reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution
provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and
other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought. None of such agreements or instruments has been assigned by the Company or its subsidiaries, and neither the
Company, its subsidiaries nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and, to the Company&rsquo;s
knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder.
To the best of the Company&rsquo;s knowledge, performance by the Company or any of its subsidiaries of the material provisions of such
agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of
any governmental agency or court, domestic or foreign, having jurisdiction over the Company, its subsidiaries or any of their assets or
businesses (each, a &ldquo;<B><U>Governmental Entity</U></B>&rdquo;), including, without limitation, those relating to environmental laws
and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>Title to Properties</U>.
Except as set forth in the Registration Statement and the Prospectus, the Company and each of its subsidiaries have good and marketable
title in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal property which are material to the
business of the Company, in each case free and clear of all liens, encumbrances, security interests, claims and defects that do not, singly
or in the aggregate, materially affect the value of such property and do not interfere with the use made and proposed to be made of such
property by the Company or any of its subsidiaries; and all of the leases and subleases material to the business of the Company, and under
which the Company or any of its subsidiaries hold properties described in the Registration Statement and the Prospectus, are in full force
and effect, and neither the Company nor any of its subsidiaries has received any notice of any material claim of any sort that has been
asserted by anyone adverse to the rights of the Company or any of its subsidiaries under any of the leases or subleases mentioned above,
or affecting or questioning the rights of the Company or any of its subsidiaries to the continued possession of the leased or subleased
premises under any such lease or sublease, which would result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo) <U>No Unlawful Contributions
or Other Payments</U>. No payments or inducements have been made or given, directly or indirectly, to any federal or local official or
candidate for, any federal or state office in the United States or foreign offices by the Company, any of its subsidiaries or any of their
officers or directors, or, to the knowledge of the Company, by any of its employees or agents or any other person in connection with any
opportunity, contract, permit, certificate, consent, order, approval, waiver or other authorization relating to the business of the Company
or any of its subsidiaries, except for such payments or inducements as were lawful under applicable laws, rules and regulations. Neither
the Company, any of its subsidiaries, nor, to the knowledge of the Company, any director, officer, agent, employee or other person associated
with or acting on behalf of the Company or any of its subsidiaries, (i) has used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political activity; (ii) made any direct or indirect unlawful payment to any government
official or employee from corporate funds; or (iii) made any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful
payment in connection with the business of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Foreign Corrupt Practices
Act</U>. None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate
or other person acting on behalf of the Company or any of its subsidiaries, is aware of or has taken any action, directly or indirectly,
that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations
thereunder (collectively, the &ldquo;<B><U>FCPA</U></B>&rdquo;), including, without limitation, making use of the mails or any means or
instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of
any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &ldquo;foreign official&rdquo;
(as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office,
in contravention of the FCPA. The Company and its subsidiaries have conducted their respective businesses in compliance with the FCPA
and have instituted and maintains policies and procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>Money Laundering Laws</U>.
The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of
all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any governmental agency (collectively, the &ldquo;<B><U>Money Laundering Laws</U></B>&rdquo;) and no action, suit or proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with
respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>OFAC</U>. None of
the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee, affiliate or person
acting on behalf of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;); and the Company will not directly or indirectly use
the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or
other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered
by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Exchange Listing</U>.
The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and is currently listed on the Exchange under the trading
symbol &ldquo;PRPO&rdquo;. Except as disclosed in the Registration Statement or the Prospectus, there is no action pending by the Company
or, to the Company&rsquo;s knowledge, the Exchange to delist the Common Stock from the Exchange, nor has the Company received any notification
that the Exchange is currently contemplating terminating such listing, except as otherwise disclosed in the Registration Statement or
Prospectus. The Company has no intention to delist the Common Stock from the Exchange or to deregister the Common Stock under the Exchange
Act, in either case, at any time during the period commencing on the date of this Agreement through and including the 90th calendar day
after the termination of this Agreement. The Placement Shares have been approved for listing on the Exchange. The issuance and sale of
the Placement Shares under this Agreement does not contravene the rules and regulations of the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(tt) <U>Margin Rules</U>.
The Company owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of Governors of the Federal Reserve
System (the &ldquo;<B><U>Federal Reserve Board</U></B>&rdquo;), and none of the proceeds from the issuance, sale and delivery of the Placement
Shares as contemplated by this Agreement and as described in the Registration Statement and the Prospectus will be used, directly or indirectly,
for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally
incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of Common Stock to be considered
a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or X of the Federal Reserve Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(uu) <U>Underwriter Agreements</U>.
The Company is not a party to any agreement with an agent or underwriter for any other &ldquo;at-the-market&rdquo; or continuous equity
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(vv) <U>Board of Directors</U>.
The qualifications of the persons serving as board members of the Company and the overall composition of the Company&rsquo;s Board of
Directors comply with the applicable requirements of the Exchange Act and the Sarbanes-Oxley Act and the listing rules of the Exchange
applicable to the Company. At least one member of the Audit Committee of the Board of Directors of the Company qualifies as an &ldquo;audit
committee financial expert,&rdquo; as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at
least a majority of the persons serving on the Board of Directors of the Company qualify as &ldquo;independent,&rdquo; as defined under
the listing rules of the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ww) <U>No Integration</U>.
Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause the offer and sale of the Placement
Shares hereunder to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration
of any such securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(xx) <U>No Material Defaults</U>.
Neither the Company nor any of its subsidiaries has defaulted on any installment on indebtedness for borrowed money or on any rental on
one or more long-term leases, which defaults, individually or in the aggregate, could reasonably be expected to result in a Material Adverse
Change. The Company has not filed a report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing of its last Annual
Report on Form 10-K, indicating that it (i) has failed to pay any dividend or sinking fund installment on preferred stock or (ii) has
defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually
or in the aggregate, could reasonably be expected to result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(yy) <U>Books and Records</U>.
The minute books of the Company and each of its subsidiaries have been made available to the Sales Agent and counsel for the Sales Agent,
and such books (i) contain a substantially complete summary of all meetings and material actions of the board of directors (including
each board committee) and stockholders of the Company (or analogous governing bodies and interest holders, as applicable) and each of
its subsidiaries since the time of its respective incorporation or organization through the date of the latest meeting and action, and
(ii) accurately in all material respects reflect all transactions referred to in such minutes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(zz) <U>Contracts Affecting
Capital</U>. There are no transactions, arrangements or other relationships between and/or among the Company, any of its affiliates (as
such term is defined in Rule 405 under the Securities Act) and any unconsolidated entity, including, but not limited to, any structured
finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&rsquo;s liquidity
or the availability of or requirements for its capital resources required to be described or incorporated by reference in the Registration
Statement and the Prospectus which have not been described or incorporated by reference as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aaa) <U>Regulations</U>.
The disclosures in the Registration Statement and the Prospectus concerning the effects of federal, state, local and all foreign regulation
on the Company&rsquo;s business in the past and as currently contemplated are correct in all material respects and no other such regulations
are required to be disclosed in the Registration Statement and the Prospectus which are not so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bbb) <U>Regulatory Matters;
Compliance</U>. The material terms of all preclinical and other nonclinical studies and clinical trials conducted by or on behalf of the
Company that are material to the Company have been adequately described in the Registration Statement or the Prospectus, in all material
respects. The clinical trials and nonclinical studies conducted by or on behalf of the Company that are described in the Registration
Statement and the Prospectus or the results of such trials and studies which are referred to in the Registration Statement and the Prospectus
were and, if still ongoing, are being conducted in material compliance with all laws and regulations applicable thereto in the jurisdictions
in which they are being conducted. The descriptions in the Registration Statement and the Prospectus of the results of such trials and
studies are accurate and complete in all material respects and fairly present the data derived from such trials and studies, and the Company
has no knowledge of any clinical trials the aggregate results of which are inconsistent with or otherwise call into question the results
of any clinical trial conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or
the results of which are referred to in the Registration Statement and the Prospectus. Except as disclosed in the Registration Statement
or the Prospectus, the Company has not received any written notices or other communications from the FDA, the European Medicines Agency
(&ldquo;<B>EMA</B>&rdquo;) or any other governmental agency or authority imposing, requiring, requesting or suggesting a clinical hold,
termination, suspension or material modification of any clinical trial that is described in the Registration Statement and the Prospectus
or the results of which are referred to in the Registration Statement and the Prospectus. Except as disclosed in the Registration Statement
or the Prospectus, the Company has not received any written notices or other communications from the FDA, the EMA or any other governmental
agency, and otherwise has no knowledge of, or reason to believe that, (i) any investigational new drug application for a potential product
of the Company is or has been rejected or determined to be non-approvable or conditionally approvable; and (ii) any license, approval,
permit or authorization to conduct any clinical trial of any potential product of the Company has been, will be or may be suspended, revoked,
modified or limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ccc) <U>Information Technology</U>.
The Company&rsquo;s information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications,
and databases (collectively, &ldquo;<B><U>IT Systems</U></B>&rdquo;) are adequate for, and operate and perform in all material respects
as required in connection with, the operation of the business of the Company as currently conducted, and to the knowledge of the Company
are free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company has implemented
and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential
information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal, personally
identifiable, sensitive, confidential or regulated data (&ldquo;<B><U>Personal Data</U></B>&rdquo;)) used in connection with their businesses,
and except as would not, individually or in the aggregate, result in a Material Adverse Change, there have been no breaches, violations,
outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the
duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company is presently
in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification.
The disclosures in the Registration Statement and the Prospectus concerning the effects of federal, state, local and all foreign regulation
on the Company&rsquo;s business in the past and as currently contemplated are correct in all material respects and no other such regulations
are required to be disclosed in the Registration Statement and the Prospectus which are not so disclosed. The Company has taken all necessary
actions to comply materially with the European Union General Data Protection Regulation and all other applicable laws and regulations
with respect to Personal Data that have been announced as of the date hereof as becoming effective within 12 months after the date hereof,
and for which any non-compliance with same would be reasonably likely to create a material liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ddd) <U>Confidentiality and
Non-Competitions</U>. To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the Company is subject to
any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer or prior employer that
could reasonably be expected to materially affect his ability to be and act in his respective capacity of the Company or be expected to
result in a Material Adverse Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(eee) <U>All Necessary Permits,
etc</U>. The Company and each of its subsidiaries holds, and is in compliance with, all franchises, grants, authorizations, licenses,
permits, easements, consents, certificates and orders (&ldquo;<B><U>Permits</U></B>&rdquo;) of any governmental or self-regulatory agency,
authority or body required for the conduct of its business, and all such Permits are in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(fff) <U>Cybersecurity</U>. (i)(x) There has been
no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and
computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and
any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<B><U>IT Systems and Data</U></B>&rdquo;)
and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are
presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Change; (iii) the Company and the Subsidiaries have implemented and
maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster
recovery technology consistent with commercially reasonable industry standards and practices. Any certificate signed by an officer of
the Company and delivered to the Sales Agent or to counsel for the Sales Agent pursuant to or in connection with this Agreement shall
be deemed to be a representation and warranty by the Company to the Sales Agent as to the matters set forth therein. The Company acknowledges
that the Sales Agent and, for purposes of the opinions to be delivered pursuant to <U>Section 7</U> hereof, counsel to the Company and
counsel to the Sales Agent, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such
reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>Covenants of the Company</U>.
The Company covenants and agrees with the Sales Agent that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Registration Statement
Amendments</U>. After the date of this Agreement and during any period in which a Prospectus relating to any Placement Shares is required
to be delivered by the Sales Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant
to Rule 153 or Rule 172 under the Securities Act), (i) the Company will notify the Sales Agent promptly of the time when any subsequent
amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and/or has
become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment
or supplement to the Registration Statement or Prospectus or for additional information; (ii) the Company will prepare and file with the
Commission, promptly upon the Sales Agent&rsquo;s reasonable request, any amendments or supplements to the Registration Statement or Prospectus
that, in the Sales Agent&rsquo;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement
Shares by the Sales Agent (<I>provided</I>, <I>however</I>, that the failure of the Sales Agent to make such request shall not relieve
the Company of any obligation or liability hereunder, or affect the Sales Agent&rsquo;s right to rely on the representations and warranties
made by the Company in this Agreement, and <I>provided</I>, <I>further</I>, that the only remedy the Sales Agent shall have with respect
to the failure to make such filing shall be to cease making sales under this Agreement until such amendment or supplement is filed); (iii)
the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by
reference, relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted
to the Sales Agent within a reasonable period of time before the filing and the Sales Agent has not reasonably objected thereto (<I>provided</I>,
<I>however</I>, that the failure of the Sales Agent to make such objection shall not relieve the Company of any obligation or liability
hereunder, or affect the Sales Agent&rsquo;s right to rely on the representations and warranties made by the Company in this Agreement,
and <I>provided</I>, <I>further</I>, that the only remedy the Sales Agent shall have with respect to the failure by the Company to obtain
such consent shall be to cease making sales under this Agreement); (iv) the Company will furnish to the Sales Agent at the time of filing
thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus,
except for those documents available via EDGAR; and (v) the Company will cause each amendment or supplement to the Prospectus, other than
documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of
the Securities Act (without reliance on Rule 424(b)(8) of the Securities Act) or, in the case of any documents incorporated by reference,
to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Notice of Commission
Stop Orders</U>. The Company will advise the Sales Agent, promptly after it receives notice or obtains knowledge thereof, of the issuance
by the Commission of any stop order suspending the effectiveness of the Registration Statement or any notice objecting to, or other order
preventing or suspending the use of, the Prospectus, of the suspension of the qualification of the Placement Shares for offering or sale
in any jurisdiction, or of the initiation of any proceeding for any such purpose or any examination pursuant to Section 8(e) of the Securities
Act, or if the Company becomes the subject of a proceeding under Section 8A of the Securities Act in connection with the offering of the
Placement Shares; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain
its withdrawal if such a stop order should be issued. Until such time as any stop order is lifted, the Sales Agent shall cease making
offers and sales under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Delivery of Prospectus;
Subsequent Changes</U>. During any period in which a Prospectus relating to the Placement Shares is required to be delivered by the Sales
Agent under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement
may be satisfied pursuant to Rule 153 or Rule 172 under the Securities Act), the Company will comply in all material respects with all
requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates
all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections
13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If during such period any event occurs as a result of which
the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary
to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the
Sales Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration
Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; <I>provided</I>,
<I>however</I>, that the Company may delay any such amendment or supplement if, in the reasonable judgment of the Company, it is in the
best interests of the Company to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Listing of Placement
Shares</U>. During any period in which the Prospectus relating to the Placement Shares is required to be delivered by the Sales Agent
under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement may
be satisfied pursuant to Rule 153 or Rule 172 under the Securities Act), the Company will use its commercially reasonable efforts to cause
the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions
as the Sales Agent reasonably designates and to continue such qualifications in effect so long as required for the distribution of the
Placement Shares; <I>provided</I>, <I>however</I>, that the Company shall not be required in connection therewith to qualify as a foreign
corporation or dealer in securities or file a general consent to service of process in any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Delivery of Registration
Statement and Prospectus</U>. The Company will furnish to the Sales Agent and its counsel (at the expense of the Company) copies of the
Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements
to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the
Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period
that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the
Sales Agent may from time to time reasonably request and, at the Sales Agent&rsquo;s request, will also furnish copies of the Prospectus
to each exchange or market on which sales of the Placement Shares may be made; <I>provided</I>, <I>however</I>, that the Company shall
not be required to furnish any document (other than the Prospectus) to the Sales Agent to the extent such document is available on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Earnings Statement</U>.
The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after
the end of the Company&rsquo;s current fiscal quarter, an earnings statement of the Company and its subsidiaries (which need not be audited)
covering a 12-month period that complies with Section 11(a) and Rule 158 of the Securities Act. The terms &ldquo;earnings statement&rdquo;
and &ldquo;make generally available to its security holders&rdquo; shall have the meanings set forth in Rule 158 under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Expenses</U>. The Company,
whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated in accordance with the provisions
of <U>Section 11</U> hereunder, will pay the following expenses all incident to the performance of its obligations hereunder, including,
but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and
supplement thereto, of each Prospectus and of each amendment and supplement thereto, (ii) the preparation, issuance and delivery of the
Placement Shares, including any stock or other transfer taxes and any stamp or other duties payable upon the sale, issuance or delivery
of the Placement Shares to the Sales Agent, (iii) the fees and disbursements of the counsel, accountants and other advisors to the Company
in connection with the transactions contemplated by this Agreement; (iv) the qualification of the Placement Shares under securities laws
in accordance with the provisions of <U>Section 7(d)</U> of this Agreement, including filing fees (<I>provided</I>, <I>however</I>, that
any fees or disbursements of counsel for the Sales Agent in connection therewith shall be paid by the Sales Agent except as set forth
in (ix) below), (v) the printing and delivery to the Sales Agent of copies of the Prospectus and any amendments or supplements thereto,
and of this Agreement, (vi) the fees and expenses incurred in connection with the listing or qualification of the Placement Shares for
trading on the Exchange, (vii) the fees and expenses of the transfer agent or registrar for the Common Stock; (viii) filing fees and expenses,
if any, of the Commission and the FINRA Corporate Financing Department (<I>provided</I>, <I>however</I>, that any fees or disbursements
of counsel for the Sales Agent in connection therewith shall be paid by the Sales Agent except as set forth in (ix) below) and (ix) the
Company shall reimburse the Sales Agent for its reasonable and documented out-of-pocket expenses (including but not limited to the reasonable
fees and documented expenses of counsel to the Sales Agent) in an amount not to exceed $15,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Use of Proceeds</U>.
The Company will use the Net Proceeds as described in the Prospectus in the section entitled &ldquo;Use of Proceeds.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Notice of Other Sales</U>.
The Company (I) shall provide the Sales Agent notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells,
grants any option to sell or otherwise disposes of any shares of Common Stock (other than Placement Shares offered pursuant to the provisions
of this Agreement) or securities convertible into or exchangeable for Common Stock, or warrants or any rights to purchase or acquire Common
Stock, during the period beginning on the fifth (5th) Trading Day immediately prior to the date on which any Placement Notice is delivered
to the Sales Agent hereunder and ending on the fifth (5th) Trading Day immediately following the final Settlement Date with respect to
Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale
of all Placement Shares covered by a Placement Notice, the fifth (5th) Trading Day immediately following the date of such suspension or
termination), and (II) will not directly or indirectly engage in any other &ldquo;at-the-market&rdquo; transaction to dispose of any shares
of Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for
shares of Common Stock, warrants or any rights to purchase or acquire, shares of Common Stock, specifically relating to the registered
 &ldquo;at-the-market&rdquo; transaction, prior to the termination of this Agreement without the prior written consent of the Sales Agent;
provided, however, that such notice requirements or restrictions, as the case may be, will not be required in connection with the Company&rsquo;s
issuance or sale of (i) shares of Common Stock, options to purchase shares of Common Stock, other equity awards or shares of Common Stock
issuable upon the exercise of options or other equity awards, pursuant to any employee or director stock option or benefits plan, stock
ownership plan or dividend reinvestment plan of the Company whether now in effect or hereafter implemented, (ii) shares of Common Stock
issuable upon exchange, conversion or redemption of securities or the exercise of warrants, options or other rights in effect or outstanding,
and disclosed in filings by the Company available on EDGAR or otherwise in writing (including by email correspondence) to the Sales Agent
and (iii) shares of Common Stock or securities convertible into or exchangeable for shares of Common Stock as consideration for mergers,
acquisitions, sale or purchase of assets or other business combinations or strategic alliances occurring after the date of this Agreement
which are not issued for capital raising purposes. Notwithstanding the foregoing, the Company shall provide the Sales Agent notice at
least two (2) days prior to pursuing any private or public offerings of equity and/or other securities (including debt securities) in
one or more transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Change of Circumstances</U>.
The Company will, at any time during a fiscal quarter in which the Company intends to tender a Placement Notice or sell Placement Shares,
advise the Sales Agent promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would
alter or affect in any material respect any opinion, certificate, letter or other document provided to the Sales Agent pursuant to this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Due Diligence Cooperation</U>.
The Company will cooperate with any reasonable due diligence review conducted by the Sales Agent or its agents in connection with the
transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate
officers, during regular business hours and at the Company&rsquo;s principal offices, as the Sales Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Required Filings Relating
to Placement of Placement Shares</U>. The Company shall set forth in each Annual Report on Form 10-K and Quarterly Report on Form 10-Q
filed by the Company with the Commission in respect of any quarter in which sales of Placement Shares were made by or through the Sales
Agent under this Agreement, with regard to the relevant period, the amount of Placement Shares sold to or through the Sales Agent, the
Net Proceeds to the Company and the compensation payable by the Company to the Sales Agent with respect to such sales of Placement Shares.
To the extent that the filing of a prospectus supplement with the Commission with respect to any sales of Placement Shares becomes required
under Rule 424(b) under the Securities Act, the Company agrees that, on or before such dates as the Securities Act shall require, the
Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act,
which prospectus supplement will set forth, with regard to the relevant period, the amount of Placement Shares sold to or through the
Sales Agent, the Net Proceeds to the Company and the compensation payable by the Company to the Sales Agent with respect to such Placement
Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were
effected as may be required by the rules or regulations of such exchange or market. The Company shall afford the Sales Agent and its counsel
with a reasonable opportunity to review and comment upon, shall consult with the Sales Agent and its counsel on the form and substance
of, and shall give due consideration to all such comments from the Sales Agent or its counsel on, any such filing prior to the issuance,
filing or public disclosure thereof; provided, however, that the Company shall not be required to submit for review (A) any portion of
any periodic reports filed with the Commission under the Exchange Act other than the specific disclosure relating to any sales of Placement
Shares and (B) any disclosure contained in periodic reports filed with the Commission under the Exchange Act if it shall have previously
provided the same disclosure for review in connection with a previous filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Representation Dates;
Certificate</U>. On or prior to the date the first Placement Notice is given hereunder and each time the Company (i) files the Prospectus
relating to the Placement Shares or amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares
(other than (A) a prospectus supplement filed in accordance with <U>Section 7(l)</U> of this Agreement or (B) a supplement or amendment
that relates to an offering of securities other than the Placement Shares) by means of a post-effective amendment, sticker, or supplement
but not by means of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Placement
Shares; (ii) files an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing amended financial information
or a material amendment to the previously filed Form 10-K); (iii) files a quarterly report on Form 10-Q under the Exchange Act; or (iv)
files a current report on Form 8-K containing amended financial information (other than an earnings release, to &ldquo;furnish&rdquo;
information pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification
of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange
Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a &ldquo;<B><U>Representation
Date</U></B>&rdquo;), the Company shall furnish the Sales Agent within three (3) Trading Days after each Representation Date with a certificate,
in the form attached hereto as <U>Exhibit 7(m)</U>. The requirement to provide a certificate under this <U>Section 7(m)</U> shall be waived
for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier
to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation
Date) and the next occurring Representation Date; <I>provided</I>, <I>however</I>, that such waiver shall not apply for any Representation
Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, if the Company subsequently decides to
sell Placement Shares following a Representation Date when the Company relied on such waiver and did not provide the Sales Agent with
a certificate under this <U>Section 7(m)</U>, then before the Company delivers the Placement Notice or the Sales Agent sells any Placement
Shares, the Company shall provide the Sales Agent with a certificate, in the form attached hereto as <U>Exhibit 7(m)</U>, dated the date
of the Placement Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Legal Opinion</U>.
On or prior to the date the first Placement Notice is given hereunder, the Company shall cause to be furnished to the Sales Agent the
written opinion and negative assurance of Goodwin Procter LLP, as counsel to the Company, or other counsel reasonably satisfactory to
the Sales Agent (&ldquo;<B><U>Company Counsel</U></B>&rdquo;), substantially in the form previously agreed between the Company and the
Sales Agent. Thereafter, within three (3) Trading Days after each Representation Date with respect to which the Company is obligated to
deliver a certificate pursuant to <U>Section 7(m)</U> for which no waiver is applicable pursuant to <U>Section 7(m)</U>, and not more
than once per calendar quarter, the Company shall cause to be furnished to the Sales Agent the written opinion and negative assurance
of each Company Counsel, as applicable, substantially in the forms previously agreed between the Company and the Sales Agent, modified,
as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented; <I>provided</I>, <I>however</I>,
that if each Company Counsel has previously furnished to the Sales Agent such written opinion and negative assurance of such counsel,
in each case substantially in the forms previously agreed between the Company and the Sales Agent, then each Company Counsel may, in respect
of any future Representation Date, furnish the Sales Agent with a letter signed by such counsel (each, a &ldquo;<B><U>Reliance Letter</U></B>&rdquo;)
in lieu of such opinion and negative assurance of such counsel to the effect that the Sales Agent may rely on the prior opinion and negative
assurance of such counsel delivered pursuant to this <U>Section 7(n)</U> to the same extent as if it were dated the date of such Reliance
Letter (except that statements in such prior opinion and negative assurance shall be deemed to relate to the Registration Statement and
the Prospectus as amended or supplemented to the date of such Reliance Letter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Comfort Letter</U>.
On or prior to the date the first Placement Notice is given hereunder and within three (3) Trading Days after each subsequent Representation
Date with respect to which the Company is obligated to deliver a certificate pursuant to Section 7(m) for which no waiver is applicable
pursuant to Section 7(m), other than a Representation Date under Section 7(m)(iii) or Section 7(m)(iv) unless with respect to a Representation
Date under Section 7(m)(iv) the Sales Agent reasonably requests delivery thereof, the Company shall cause its independent accountants
to furnish the Sales Agent letters (the &ldquo;<B><U>Comfort Letters</U></B>&rdquo;), dated the date that the Comfort Letter is delivered,
in form and substance satisfactory to the Sales Agent, (i) confirming that they are an independent registered public accounting firm within
the meaning of the Securities Act, the Exchange Act and the rules and regulations of the PCAOB and are in compliance with the applicable
requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, (ii) stating, as of such
date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&rsquo;
 &ldquo;comfort letters&rdquo; to the Sales Agent in connection with registered public offerings (the first such letter, the &ldquo;<B><U>Initial
Comfort Letter</U></B>&rdquo;) and (iii) updating the Initial Comfort Letter with any information that would have been included in the
Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus,
as amended and supplemented to the date of such letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) <U>Market Activities</U>.
The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably
be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
of the Common Stock or (ii) sell, bid for, or purchase shares of Common Stock in violation of Regulation M, or pay anyone any compensation
for soliciting purchases of the Placement Shares other than the Sales Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>. The
Company and its subsidiaries shall maintain insurance in such amounts and covering such risks as is reasonable and customary for the business
in which it is engaged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) <U>Investment Company
Act</U>. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor its subsidiaries or, after
giving effect to the offering and sale of the Placement Shares and the application of proceeds therefrom as described in the Prospectus,
will be, an &ldquo;investment company&rdquo; within the meaning of such term under the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <U>Securities Act and
Exchange Act</U>. The Company will use its reasonable best efforts to comply with all requirements imposed upon it by the Securities Act
and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement
Shares as contemplated by the provisions hereof and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <U>No Offer to Sell</U>.
Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Sales Agent in its capacity
as principal or agent hereunder, neither the Sales Agent nor the Company (including its agents and representatives, other than the Sales
Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405
under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to
buy Placement Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) <U>Sarbanes-Oxley Act</U>.
The Company and its subsidiaries will use their reasonable best efforts to comply with all effective applicable provisions of the Sarbanes-Oxley
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) <U>Transfer Agent</U>.
The Company shall maintain, at its sole expense, a registrar and transfer agent for the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Conditions to the Sales
Agent&rsquo;s Obligations</U>. The obligations of the Sales Agent hereunder with respect to a Placement will be subject to the continuing
accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its
obligations hereunder, to the completion by the Sales Agent of a due diligence review satisfactory to the Sales Agent in its reasonable
judgment, and to the continuing satisfaction (or waiver by the Sales Agent in its sole discretion) of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Registration Statement
Effective</U>. The Registration Statement shall be effective and shall be available for the sale of all Placement Shares contemplated
to be issued by any Placement Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Securities Act Filings
Made</U>. The Company shall have filed with the Commission the ATM Prospectus pursuant to Rule 424(b) under the Securities Act not later
than the Commission&rsquo;s close of business on the second Business Day following the date of this Agreement. All other filings with
the Commission required by Rule 424(b) or Rule 433 under the Securities Act to have been filed prior to the issuance of any Placement
Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424(b) (without reliance on
Rule 424(b)(8) of the Securities Act) or Rule 433, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>No Material Notices</U>.
None of the following events shall have occurred and be continuing: (i) receipt by the Company or any of its subsidiaries of any request
for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness
of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement
or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of
any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for
sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv) the occurrence of any event that makes
any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related
Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading
and, that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No Misstatement or
Material Omission</U>. The Sales Agent shall not have advised the Company that the Registration Statement or Prospectus, or any amendment
or supplement thereto, contains an untrue statement of fact that in the Sales Agent&rsquo; reasonable opinion is material, or omits to
state a fact that in the Sales Agent&rsquo; reasonable opinion is material and is required to be stated therein or is necessary to make
the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Material Changes</U>.
Except as contemplated in the Prospectus, or disclosed in the Company&rsquo;s reports filed with the Commission, there shall not have
been any material adverse change in the authorized capital stock of the Company or any Material Adverse Change or any development that
could reasonably be expected to result in a Material Adverse Change, or any downgrading in or withdrawal of the rating assigned to any
of the Company&rsquo;s securities (other than asset backed securities) by any rating organization or a public announcement by any rating
organization that it has under surveillance or review its rating of any of the Company&rsquo;s securities (other than asset backed securities),
the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Sales
Agent (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable
or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated by this Agreement and
the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Representation Certificate</U>.
The Sales Agent shall have received the certificate required to be delivered pursuant to <U>Section 7(m)</U> on or before the date on
which delivery of such certificate is required pursuant to <U>Section 7(m)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Legal Opinions</U>.
The Sales Agent shall have received the opinion and negative assurance of each Company Counsel as required to be delivered pursuant <U>Section
7(n)</U> on or before the date on which delivery of such opinion and negative assurance is required pursuant to <U>Section 7(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Comfort Letter</U>.
The Sales Agent shall have received the Comfort Letter required to be delivered pursuant <U>Section 7(o)</U> on or before the date on
which delivery of such Comfort Letter is required pursuant to <U>Section 7(o)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Officer&rsquo;s Certificate</U>.
On or prior to the date the first Placement Notice is given hereunder, the Sales Agent shall have received a certificate, signed on behalf
of the Company by its Chief Financial Officer, certifying as to (i) the certificate of incorporation of the Company (as the same may be
amended or restated from time to time), (ii) the bylaws of the Company (as the same may be amended or restated from time to time), (iii)
the resolutions of the Board of Directors of the Company (or a committee thereof) authorizing the execution, delivery and performance
of this Agreement and the issuance of the Placement Shares and (iv) the incumbency of the officers duly authorized to execute this Agreement
and the other documents contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>No Suspension</U>.
Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Other Materials</U>.
On each date on which the Company is required to deliver a certificate pursuant to <U>Section 7(m)</U>, the Company shall have furnished
to the Sales Agent such appropriate further opinions, certificates, letters and documents as the Sales Agent may have reasonably requested.
All such opinions, certificates, letters and other documents shall have been in compliance with the provisions hereof. The Company will
furnish the Sales Agent with such conformed copies of such opinions, certificates, letters and other documents as the Sales Agent shall
have reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Approval for Listing</U>.
The Placement Shares shall either have been (i) approved for listing on the Exchange, subject only to notice of issuance, or (ii) the
Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>No Termination Event</U>.
There shall not have occurred any event that would permit the Sales Agent to terminate this Agreement pursuant to <U>Section 11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>FINRA</U>. The Sales
Agent shall have received a letter from the Corporate Financing Department of FINRA confirming that such department has determined to
raise no objection with respect to the fairness or reasonableness of the terms and arrangements related to the sale of the Placement Shares
pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. <U>Indemnification and
Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Company Indemnification</U>.
The Company agrees to indemnify and hold harmless the Sales Agent, the directors, officers, members, partners, employees and agents of
the Sales Agent, each broker dealer affiliate of the Sales Agent, and each Sales Agent Affiliate, if any, from and against any and all
losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable investigative, legal and other
expenses incurred in connection with, and any and all amounts paid in settlement (in accordance with <U>Section 9(c)</U>) of, any action,
suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third
party, or otherwise, or any claim asserted), as and when incurred, to which the Sales Agent, or any such person, may become subject under
the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such
losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or supplement thereto or
in any Issuer Free Writing Prospectus or in any application or other document executed by or on behalf of the Company or based on written
information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify the Common Stock under the securities
laws thereof or filed with the Commission, (y) the omission or alleged omission to state in any such document a material fact required
to be stated in it or necessary to make the statements in it not misleading or (z) any breach by any of the indemnifying parties of any
of their respective representations, warranties and agreements contained in this Agreement; <I>provided, however</I>, that this indemnity
agreement shall not apply to the extent that such loss, claim, liability, expense or damage arises from the sale of the Placement Shares
pursuant to this Agreement and is caused directly by an untrue statement or omission made in reliance upon and in strict conformity with
written information relating to the Sales Agent and furnished to the Company by the Sales Agent or its agents expressly for inclusion
in any document as described in clause (x) of this <U>Section 9(a)</U>. This indemnity agreement will be in addition to any liability
that the Company might otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>The Sales Agent Indemnification</U>.
The Sales Agent agrees to indemnify and hold harmless the Company and its directors and each officer of the Company that signed the Registration
Statement, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act or (ii) is controlled by or is under common control with the Company (each, a &ldquo;<B><U>Company Affiliate</U></B>&rdquo;)
from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable
investigative, legal and other expenses incurred in connection with, and any and all amounts paid in settlement (in accordance with <U>Section
9(c)</U>) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified
party and any third party, or otherwise, or any claim asserted), as and when incurred, to which any such Company Affiliate, may become
subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise,
insofar as such losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or
supplement thereto, or (y) the omission or alleged omission to state in any such document a material fact required to be stated in it
or necessary to make the statements in it not misleading; <I>provided</I>, <I>however</I>, that this indemnity agreement shall apply only
to the extent that such loss, claim, liability, expense or damage is caused directly by an untrue statement or omission made in reliance
upon and in strict conformity with written information relating to the Sales Agent and furnished to the Company by the Sales Agent or
its agents expressly for inclusion in any document as described in clause (x) of this <U>Section 9(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Procedure</U>. Any
party that proposes to assert the right to be indemnified under this <U>Section 9</U> will, promptly after receipt of notice of commencement
of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this <U>Section
9</U>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission
so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified
party otherwise than under this <U>Section 9</U> and (ii) any liability that it may have to any indemnified party under the foregoing
provision of this <U>Section 9</U> unless, and only to the extent that, such omission results in the forfeiture of substantive rights
or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party
of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written
notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly
with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the
indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying
party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable
costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have
the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense
of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying
party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it
or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential
conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which
case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the
indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice
of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the
expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any
proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more
than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees,
disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred. An indemnifying party will
not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall,
without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending
or threatened claim, action or proceeding relating to the matters contemplated by this <U>Section 9</U> (whether or not any indemnified
party is a party thereto), unless such settlement, compromise or consent includes an unconditional release of each indemnified party from
all liability arising or that may arise out of such claim, action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Contribution</U>. In
order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs
of this <U>Section 9</U> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or the
Sales Agent, the Company and the Sales Agent will contribute to the total losses, claims, liabilities, expenses and damages (including
any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action,
suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than the Sales
Agent, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration
Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Sales Agent may be subject
in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Sales Agent
on the other. The relative benefits received by the Company on the one hand and the Sales Agent on the other hand shall be deemed to be
in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company
bear to the total compensation received by the Sales Agent from the sale of Placement Shares on behalf of the Company. If, but only if,
the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in
such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative
fault of the Company, on the one hand, and the Sales Agent, on the other, with respect to the statements or omission that resulted in
such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with
respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or
the Sales Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such
statement or omission. The Company and the Sales Agent agree that it would not be just and equitable if contributions pursuant to this
<U>Section 9(d)</U> were to be determined by pro rata allocation or by any other method of allocation that does not take into account
the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability,
expense, or damage, or action in respect thereof, referred to above in this <U>Section 9(d)</U> shall be deemed to include, for the purpose
of this <U>Section 9(d)</U>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim to the extent consistent with <U>Section 9(c)</U> hereof. Notwithstanding the foregoing provisions
of this <U>Section 9(d)</U>, the Sales Agent shall not be required to contribute any amount in excess of the commissions received by it
under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities
Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this <U>Section
9(d)</U>, any person who controls a party to this Agreement within the meaning of the Securities Act will have the same rights to contribution
as that party (and any officers, directors, members, partners, employees or agents of the Sales Agent and each broker dealer affiliate
of the Sales Agent will have the same rights to contribution as the Sales Agent), and each officer of the Company who signed the Registration
Statement and each director of the Company will have the same rights to contribution as the Company, subject in each case to the provisions
hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect
of which a claim for contribution may be made under this <U>Section 9(d)</U>, will notify any such party or parties from whom contribution
may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other
obligation it or they may have under this <U>Section 9(d)</U> except to the extent that the failure to so notify such other party materially
prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant
to the last sentence of <U>Section 9(c)</U> hereof, no party will be liable for contribution with respect to any action or claim settled
without its written consent if such consent is required pursuant to <U>Section 9(c)</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. <U>Representations and
Agreements to Survive Delivery</U>. The indemnity and contribution agreements contained in <U>Section 9</U> of this Agreement and all
representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective
dates, regardless of (i) any investigation made by or on behalf of the Sales Agent, any controlling person of the Sales Agent, or the
Company (or any of their respective officers, directors, members or controlling persons), (ii) delivery and acceptance of the Placement
Shares and payment therefor or (iii) any termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Sales Agent shall
have the right by giving notice as hereinafter specified at any time to terminate this Agreement if (i) any Material Adverse Change, or
any development that could reasonably be expected to result in a Material Adverse Change has occurred that, in the reasonable judgment
of the Sales Agent, may materially impair the ability of the Sales Agent to sell the Placement Shares hereunder, (ii) the Company shall
have failed, refused or been unable to perform any agreement on its part to be performed hereunder; <I>provided</I>, <I>however</I>, in
the case of any failure of the Company to deliver (or cause another person to deliver) any certification, opinion, or letter required
under <U>Sections 7(m)</U>, <U>7(n)</U> or <U>7(o)</U>, the Sales Agent&rsquo;s right to terminate shall not arise unless such failure
to deliver (or cause to be delivered) continues for more than thirty (30) days from the date such delivery was required, (iii) any other
condition of the Sales Agent&rsquo;s obligations hereunder is not fulfilled, or (iv) any suspension or limitation of trading in the Placement
Shares or in securities generally on the Exchange shall have occurred (including automatic halt in trading pursuant to market-decline
triggers, other than those in which solely program trading is temporarily halted), or a major disruption of securities settlements or
clearing services in the United States shall have occurred, or minimum prices for trading have been fixed on the Exchange. Any such termination
shall be without liability of any party to any other party except that the provisions of <U>Section 7(g)</U> (Expenses), <U>Section 9</U>
(Indemnification and Contribution), <U>Section 10</U> (Representations and Agreements to Survive Delivery), <U>Section 11(f)</U>, <U>Section
16</U> (Applicable Law; Consent to Jurisdiction) and <U>Section 17</U> (Waiver of Jury Trial) hereof shall remain in full force and effect
notwithstanding such termination. If the Sales Agent elects to terminate this Agreement as provided in this <U>Section 11(a)</U>, the
Sales Agent shall provide the required notice as specified in <U>Section 12</U> (Notices).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The Company shall have
the right, by giving five (5) days&rsquo; notice as hereinafter specified in <U>Section 12</U>, to terminate this Agreement in its sole
discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party
except that the provisions of <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U> and <U>Section
17</U> hereof shall remain in full force and effect notwithstanding such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Sales Agent shall
have the right, by giving five (5) days&rsquo; notice as hereinafter specified in <U>Section 12</U>, to terminate this Agreement in its
sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other
party except that the provisions of <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U>
and <U>Section 17</U> hereof shall remain in full force and effect notwithstanding such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) Unless earlier terminated
pursuant to this <U>Section 11</U>, this Agreement shall automatically terminate upon the earlier to occur of (i) issuance and sale of
all of the Placement Shares to or through the Sales Agent on the terms and subject to the conditions set forth herein and (ii) the expiration
of the Registration Statement on the third (3<FONT STYLE="font-size: 10pt"><SUP>rd</SUP></FONT>) anniversary of the initial effective
date of the Registration Statement pursuant to Rule 415(a)(5) under the Securities Act; <I>provided</I> that the provisions of <U>Section
7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U> and <U>Section 17</U> hereof shall remain in full
force and effect notwithstanding such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) This Agreement shall remain
in full force and effect unless terminated pursuant to <U>Sections 11(a)</U>, <U>(b)</U>, <U>(c)</U> or <U>(d)</U> above or otherwise
by mutual agreement of the parties; <I>provided</I>, <I>however</I>, that any such termination by mutual agreement shall in all cases
be deemed to provide that <U>Section 7(g)</U>, <U>Section 9</U>, <U>Section 10</U>, <U>Section 11(f)</U>, <U>Section 16</U> and <U>Section
17</U> shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) Any termination of this
Agreement shall be effective on the date specified in such notice of termination; <I>provided</I>, <I>however</I>, that such termination
shall not be effective until the close of business on the date of receipt of such notice by the Sales Agent or the Company, as the case
may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such termination shall not become
effective until the close of business on such Settlement Date and such Placement Shares shall settle in accordance with the provisions
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12. <U>Notices</U>. All notices
or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall
be in writing, unless otherwise specified, and if sent to the Sales Agent, shall be delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A.G.P./Alliance Global Partners</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">590 Madison Avenue, 28<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>
Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Tom Higgins</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: atm@allianceg.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">with a copy (which shall not constitute notice)
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Sheppard, Mullin, Richter &amp;
Hampton LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">30 Rockefeller Center, 39<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10112<BR>
Attention: Richard A. Friedman, Esq.<BR>
Email: rafriedman@sheppardmullin.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and if to the Company, shall be delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Precipio, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">4 Science Park</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">New Haven, CT 06511</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Attention: Ilan
Danieli, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Email: idanieli@precipiodx.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">with a copy (which shall not constitute notice)
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Goodwin Procter LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">The New York Times Building</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">620 Eighth Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: Stephen M. Davis, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: sdavis@goodwinlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each party may change such
address for notices by sending to the other party to this Agreement written notice of a new address for such purpose. Each such notice
or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to
follow) on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business
Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually
received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this
Agreement, &ldquo;<B><U>Business Day</U></B>&rdquo; shall mean any day on which the Exchange and commercial banks in the City of New York
are open for business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An electronic communication
(&ldquo;<B><U>Electronic Notice</U></B>&rdquo;) shall be deemed written notice for purposes of this <U>Section 12</U> if sent to the electronic
mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party sending
Electronic Notice receives confirmation of receipt by the receiving party (other than pursuant to auto-reply). Any party receiving Electronic
Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (&ldquo;<B><U>Nonelectronic Notice</U></B>&rdquo;)
which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13. <U>Successors and Assigns</U>.
This Agreement shall inure to the benefit of and be binding upon the Company and the Sales Agent and its successors and permitted assigns
and, as to <U>Sections 5(b) </U>and <U>9</U>, the other indemnified parties specified therein. References to any of the parties contained
in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or
implied, is intended to confer upon any other person any rights, remedies, obligations or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior
written consent of the other party; <I>provided</I>, <I>however</I>, that the Sales Agent may assign its rights and obligations hereunder
to an affiliate of the Sales Agent without obtaining the Company&rsquo;s consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14. <U>Adjustments for Share
Splits</U>. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into
account any share split, share dividend or similar event effected with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15. <U>Entire Agreement; Amendment;
Severability</U>. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) and
any other writing entered into by the parties relating to this Agreement constitutes the entire agreement and supersedes all other prior
and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof.
Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Sales
Agent. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid,
illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to
the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed
as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to
such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16. <U>Applicable Law; Consent
to Jurisdiction</U>. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York,
without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the
state and federal courts sitting in the City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection
with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return
receipt requested) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17. <U>Waiver of Jury Trial</U>.
The Company and the Sales Agent each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based
upon or arising out of this Agreement or any transaction contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18. <U>Absence of Fiduciary
Relationship</U>. The Company acknowledges and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) the Sales Agent is acting
solely as agent in connection with the sale of the Placement Shares contemplated by this Agreement and the process leading to such transactions,
and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders),
creditors or employees or any other party, on the one hand, and the Sales Agent, on the other hand, has been or will be created in respect
of any of the transactions contemplated by this Agreement, irrespective of whether the Sales Agent has advised or is advising the Company
on other matters, and the Sales Agent has no obligation to the Company with respect to the transactions contemplated by this Agreement,
except the obligations expressly set forth in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) the Company is capable
of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) the Sales Agent has not
provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement, and the Company
has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) the Company has been advised
and is aware that the Sales Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ
from those of the Company and that the Sales Agent has no obligation to disclose such interests and transactions to the Company by virtue
of any fiduciary, advisory or agency relationship; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) the Company waives, to
the fullest extent permitted by law, any claims it may have against the Sales Agent, for breach of fiduciary duty or alleged breach of
fiduciary duty and agrees that the Sales Agent shall have no liability (whether direct or indirect, in contract, tort or otherwise) to
the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company,
including stockholders, partners, employees or creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19. <U>Use of Information</U>.
The Sales Agent may not provide any information gained in connection with this Agreement and the transactions contemplated by this Agreement,
including due diligence, to any third party other than its legal counsel advising it on this Agreement unless expressly approved by the
Company in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20. <U>Counterparts</U>. This
Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21. <U>Effect of Headings;
Knowledge of the Company</U>. The section and Exhibit headings herein are for convenience only and shall not affect the construction hereof.
All references in this Agreement to the &ldquo;knowledge of the Company&rdquo; or the &ldquo;Company&rsquo;s knowledge&rdquo; or similar
qualifiers shall mean the actual knowledge of the directors and officers of the Company, after due inquiry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22. <U>Definitions</U>. As
used in this Agreement, the following term has the meaning set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<I>Applicable Time</I>&rdquo;
means the date of this Agreement, each Representation Date, each date on which a Placement Notice is given, each Point of Sale, and each
Settlement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Remainder of Page Intentionally Blank]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing correctly
sets forth the understanding between the Company and the Sales Agent, please so indicate in the space provided below for that purpose,
whereupon this letter shall constitute a binding agreement between the Company and the Sales Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 42%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="text-transform: uppercase"><B>PRECIPIO, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">Ilan Danieli</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Chief Executive Officer and Director</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>ACCEPTED as of the date first-above written:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>A.G.P./ALLIANCE GLOBAL PARTNERS</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: </TD>
    <TD STYLE="font-size: 10pt">Tom Higgins</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Managing Director</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 28; Options: NewSection; Value: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>SCHEDULE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Placement Notice</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 1.5in">From:</TD>
    <TD STYLE="font-size: 10pt">Precipio, Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">To:</TD>
    <TD STYLE="font-size: 10pt">A.G.P./Alliance Global Partners</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Attention: [&#9679;] </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Subject:</TD>
    <TD STYLE="font-size: 10pt">Placement Notice</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Date:</TD>
    <TD STYLE="font-size: 10pt">[&#9679;], 202[&#9679;]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the terms and
subject to the conditions contained in the Sales Agreement (the &ldquo;<B><U>Sales Agreement</U></B>&rdquo;) between Precipio, Inc.,
a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and A.G.P./Alliance Global Partners (the &ldquo;<B><U>Sales Agent</U></B>&rdquo;),
dated April [ ], 2023, the Company hereby requests that the Sales Agent sell up to [&#9679;] shares of the Company&rsquo;s common stock,
par value $0.01 per share (the &ldquo;<B><U>Placement Shares</U></B>&rdquo;), at a minimum market price of $[&#9679;] per share, during
the time period beginning [month, day, time] and ending [month, day, time] [and with no more than [&#9679;] Placement Shares sold in
any one Trading Day].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">[The Company may include such
other sale parameters as it deems appropriate.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used and
not defined herein shall have the respective meanings assigned to them in the Sales Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>SCHEDULE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Notice Parties</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Precipio, Inc.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ilan Danieli (idanieli@precipiodx.com)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Miri Radomski (mradomski@precipiodx.com)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>The Sales Agent</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tom Higgins (thiggins@allianceg.com)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">atm@allianceg.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>SCHEDULE 3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Compensation</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company shall pay to the Sales Agent in cash,
upon each sale of Placement Shares through the Sales Agent pursuant to this Agreement, an amount equal to 3.00% of the aggregate gross
proceeds from each sale of Placement Shares.*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt">*</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">The foregoing rate of compensation shall not apply when the Sales Agent purchases Placement Shares on a principal basis, in which case the Company may sell the Placement Shares to the Sales Agent as principal at a price to be mutually agreed upon by the Company and the Sales Agent at the relevant Point of Sale pursuant to the applicable Placement Notice (it being hereby acknowledged and agreed that the Sales Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to the Sales Agreement, except as otherwise agreed by the Sales Agent and the Company in writing and expressly set forth in a Placement Notice).</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Value: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit 7(m)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>OFFICER CERTIFICATE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>The undersigned, the duly
qualified and appointed Chief Financial Officer of Precipio, Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;),
does hereby certify in such capacity and on behalf of the Company, pursuant to <U>Section 7(m)</U> of the Sales Agreement, dated April
[ ], 2023 (the &ldquo;<B><U>Sales Agreement</U></B>&rdquo;), between the Company and A.G.P./Alliance Global Partners, that:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt">(i)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the representations and warranties of the Company in <U>Section 6</U> of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date; and;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt">(ii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt">(iii)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">as of the date hereof, (i) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading, (ii) the Prospectus does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result of which it is necessary to amend or supplement the Registration Statement or the Prospectus in order to make the statements therein not untrue or misleading for clauses (i) and (ii) above, respectively, to be true and correct;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt">(iv)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">there has been no Material Adverse Change since the date as of which information is given in the Prospectus, as amended or supplemented;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt">(v)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the Company does not currently possess any material non-public information; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt">(vi)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">the aggregate offering price of the Placement Shares that may be issued and sold pursuant to the Sales Agreement and the maximum number or amount of Placement Shares that may be sold pursuant to the Sales Agreement have been duly authorized by the Company&rsquo;s Board of Directors or a duly authorized committee thereof.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Terms used herein and not defined herein have
the meanings ascribed to them in the Sales Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt">Dated: April <FONT STYLE="background-color: yellow">[&nbsp;&nbsp;]</FONT>, 2023</TD>
    <TD STYLE="width: 5%; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: </TD>
    <TD STYLE="font-size: 10pt">Matthew Gage</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>prpo-20230414.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaOMObOdzZR+SYkxtmB7bRla3y4p/Qlp8CJJLLt20RoM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:PRPO="http://precipiodx.com/20230414" elementFormDefault="qualified" targetNamespace="http://precipiodx.com/20230414">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://precipiodx.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="prpo-20230414_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="prpo-20230414_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>prpo-20230414_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>prpo-20230414_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://precipiodx.com/role/Cover" xlink:href="prpo-20230414.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://precipiodx.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140584926847168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 14,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRECIPIO,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001043961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1789357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4 Science Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Haven<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">787-7888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRPO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2312629d2_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prpo-20230414.xsd" xlink:type="simple"/>
    <context id="From2023-04-14to2023-04-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001043961</identifier>
        </entity>
        <period>
            <startDate>2023-04-14</startDate>
            <endDate>2023-04-14</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-04-14to2023-04-14">0001043961</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-04-14to2023-04-14">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-04-14to2023-04-14">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-04-14to2023-04-14">2023-04-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-04-14to2023-04-14">PRECIPIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-04-14to2023-04-14">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-04-14to2023-04-14">001-36439</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-04-14to2023-04-14">91-1789357</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-04-14to2023-04-14">4 Science Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-04-14to2023-04-14">New Haven</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-04-14to2023-04-14">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-04-14to2023-04-14">06511</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-04-14to2023-04-14">203</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-04-14to2023-04-14">787-7888</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-04-14to2023-04-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-04-14to2023-04-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-04-14to2023-04-14">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-04-14to2023-04-14">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-04-14to2023-04-14">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-04-14to2023-04-14">PRPO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-04-14to2023-04-14">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-04-14to2023-04-14">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ [(N.5I>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ [(N.5B0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #LBXY6,CB*Q^X    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #L
MBXY6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( .R+CE8S$J*00P0  '$0   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #L
MBXY6GZ ;\+$"  #B#   #0              @ &&#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( .R+CE:7BKL<P    !,"   +              "  6(/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .R+CE:JQ"(6,P$  "("   /
M          "  4L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #LBXY6
M)!Z;HJT   #X 0  &@              @ &K$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " #LBXY699!YDAD!  #/ P  $P
M        @ &0$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  #:$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2312629d2_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://precipiodx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2312629d2_8k.htm">tm2312629d2_8k.htm</File>
    <File>prpo-20230414.xsd</File>
    <File>prpo-20230414_lab.xml</File>
    <File>prpo-20230414_pre.xml</File>
    <File>tm2312629d2_ex1-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2312629d2_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2312629d2_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prpo-20230414_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prpo-20230414_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prpo-20230414.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "PRPO",
   "nsuri": "http://precipiodx.com/20230414",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2312629d2_8k.htm",
      "contextRef": "From2023-04-14to2023-04-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://precipiodx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2312629d2_8k.htm",
      "contextRef": "From2023-04-14to2023-04-14",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://precipiodx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-23-045710-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-045710-xbrl.zip
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M"YV+%S5JET.G@06NZ7T"U++=Q5 E#A8CT^% DO(PI.(\TE2[9='#44OIFB#
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MZ33L/*1B(#OJ!CEOH52.00TM+K>9R!PC6S(&&=QW/'>1#;]NE,." <+UEA>
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MUGZF-.0:D3@<;">66,^J"5G)-:2P9"ZTG4 7UP5KR%QPT4RH'FAV]X7TIP
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M5]&YNC)OCK<__#8[JM;MCQ\.W[U3)/E_4$L#!!0    ( .R+CE9)%$\=E:H
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M2EYHJON+S/&1GX$N#_X>C/%]+;"R(DV+WWB&SD_;U-4L>UKT1?9S@1_A,E_
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M[&&2@H%YQNXH_MIGQG\%67K=-C.P#RD!B ']8-UU+/)RH_ H,PH+7:ZJOTM
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M5=4E'5%^%"4#0W<ER(+R&DF841?NT'(ILY/L:;K2VZCO/,C"VI6NU?%>,!G
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M4/:(SW GWR>A_OTXM9L-M"[V18K4;LK7F2%6GL)4)*IA+' BU25$AQQUC&*
M/(,X!MVCI&D:^G[,3OEQ3SD#(\<W]%3IB9IYQM$_&V?(_7)BU;]9#?KI'S3Y
M7*:>>H10VNRU@!+Y!]L)K"@&-/@*5*Y[Y;X+>- <L\+V18M7C&#LQ&Z GSC<
ML!2#]Z9IUNC*.C$3,56-P4=+P.+PN0/?S(;U \='=RP@D AP(38F%PJ43,+(
M-H:U1W-'VBW_0'"\CW=S/1*9A8)>YR2_WL#P-&,47!NU:?M>@,J9WX9T3ZG"
M>=]SPY1GWT8Q*HE\#$MUK\K()@X5:\+\%3:-T K6_'$SE>B4%@CXN#A&(JDF
M3BQ<KM5R6A23/:GN>S&_J6,?HL2EY;%VH6P\6,2X@3N_I,0DD?X].C^_-YF>
M3+XY 25)_5YD?A[I^$(;^KSQYM*%FDLY?#P[B^ZSYR]^?7,Q+*9A5B//-=KU
MY;HSP#6#-3\^HF=(WHF%ITMB*-V/QI@+%:(4YK.<2)(;)3:/>[Y^]_@H) 4I
M36;?&](N7J@_RQU8!AGY/:1D1S2;8T$L(HM>)N-(]N(:1Y\VV[6N 5T<IT \
M_ZB+9+K*S 2+EN2B>AI+&)+\"6.1;]_?<I+JWS<;\K=AB1\??K*-7GM:65M8
M2]9+QEH"Y;_J<\- BV*"PDN$L=.JU^1T55\C'DEKJ<#6- 9@H W]LY2?%D>3
MCZ6CS=5CR&B%3R+GI+D6MX6VY#Z/I")@K7%"D=U9Y.39X<4(U<E(GQ/QJ[0Z
MMY".%($WEXLOQSE5]/>B1DEP8Z"H3HC<T256NQX=4@<Z<Z@E[+11]C=E&91%
MN7L!1\, 8FD5+V.*[R@N>P[8[)!9OZ(N*T$YH=B8E.W4FY:7HNO"9H1S//GS
M 8.QD!=WCH\IC/>?Y%H<ZHMYJ!7NU-:>*N#)E8SMFX=/, 5Z0+*[?L:J'\%2
M<^6/6XH=N<;\'YV"_5)#B"UIHE^**7I.5;=&8AE?@Z!:I[\;8[77!^+]&IW%
M]%_N<&YS-Q7O$#L,QO%TU<I)QW-0_+O=$1%H @6G1&GX^ ]6?')->W \D:09
MV69\R(?B!O-;3W(IVK@A[<7\G$U[8&+6<?H_H@QY KM5((##V*"_$#P%1="$
MG;^GJ&?5:<T'*C+.BSK#>(21!-4ZRC3'+)EZU!I;)D>*$ [* =X@"?=5M09!
M+BF&GELEBYRD]0:98C<MLGL5L_?%)7U)%"W]]Z8CDEM?[9L+()H^71:(.9;?
MK!HY'04V4J+TL:>VH'1FRT&@%0*_4"4R (RJB4%;XWVUT - JM\,,*PZ'J+F
M0UL[VH>!U8U>G^KCV2Y]G'T&=?R80I5ZF6AS2HZ&WA3L2"]+A)%@NPSA:^<_
M>)\OZD3O3717"AT>:7>4$=Q[*<P7J% 885PWM9<TXWY&BZ?G'_XFS1M-] )S
ML)IMR;E3(]$$1VXPEE<1?9^O-%KZ4AI#X]AK"R];8NLH#.*119L>O''8)1X#
M7M*T&;T5FY..<DAJS,"!CCYHA7!(T?=$@Q6[J@'(I:K]:P:!-:XE7Y@9!N^#
M,3\EJ5$HH_0T]?W=2*-SIZ%Q@_J*>Q<YPK25Y.4#@]H8VU[BM(NGR-?QT8B
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M^,C&\RTJH"]G5TST9I/$PD>D- M(H;ULY#9L]I5_5B$VZWM\Q.)J&4??H\N
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M8$P?+#V5GW ",>:KM+=-:SJVDR<DM,(C=YP4V Y-CH PGC6C(&QE9*-+;0!
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M:RI<N\(D?IL!!6J12*']TX8QK#=NS;/?=-%_:HIVCO]@O%#3^@BHI/G>E-A
M&,[#6^)P2%2C1=_D9P[CEVS(^^BTN^C=@56QRUGF&+FQQ"29RXY_+ 729VAD
M.R4HQWQ+L#EA;,!_@E1WVNFN:-M;;>P:;F':5H'K<3.3'R.FLM4?!X3WDEA'
MK=M6\$R$K6 44<&"C0ZC=(-(C4"2M38-*B/A%ZP04\ 5-A:PT/$^P+\"E<H
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M4#!V-*0:E*)T;Q":\FPB%:S1+G ((RJ#0]J]S@5=F*72&$WP=JF3"\$R#NR
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MC%-1X+\[3J=8G[JJZE>>NMI;-9;/>DAX99)2PZR*5TQBI[JVLS(*L3.H-+E
MK%XQN]5ZM/6R[(.6P1_1[5T;"VH$<Q,R=D??9@)O</S3#-YNS#0T5,:I:GP$
ML">+^'=D2O12LR2IVIG.=<4,U\P_DH'1K2;7$N.2I]/Q06AQ2S-PW8,-)'#.
MDL(M>41JOC^L0X,]"@C'D(J?@_6ONMX?DI%0N\O!F^O!54(B#-IQ)JBJ4L=Q
MA/70&]7:=UT8H*:W27[) ]-VTD4]<MF$!N'XZ"6HB#&& TK4C-<SXC\OWKVT
MUO6@$]J.TFW?X$.09.$K?"./I5 ^.CH,):XO\41F/^F?D<TRS6 9=93.+M"2
M)(-:V=P8F!M-TA8KVQDU6H#_X,'X[& 5?+*+%S)9AZN!6>,V#A#A9DOH<:3;
M3?C"V%CDVPIC*]X/$BQQ8'*I8(AF-%&*DU:A*AAE-=^8?)OHK$[VO5V-"')W
M:*=MIL[K2RTRXIW4O,*O5#02WS#4[::S>\PP?4D]3NT5]SUE&XA!:=T/[FMI
MJ+Q(!.L60JQ#> RIF/ WFTW6NB)S<Q :VZIY4<ZI0QV1]^$!N\1H;XVBBV55
M[%F"%SID$$:@IBI^CO%N[=.1BYF#M(B,&I5Z#,HDR^&48O+_O[UK[8W;R++?
M!>@_$-Z=@31@%$FVD]C.&B/+<J)=QS9D90>#(!^H)B5QS"9[2+;DWE^_=5]5
MM\AB=\O6RVXC@".IV62QZM:M^SPGW"'7[SV<EPG&#C$_L/#,T7?8_>IF_;.F
M1_(Q;04<';C+"?F7@&G.,W^N%E":\,B1X5MYQC.)HJ*2.Y6T$V,A2EO;D#QQ
M:S[2,TL (%0FH;&!3T.%'@ \*7"=*%_]0I!R-A@?)FC=I+"XP9KV,/3FB,R1
MF:F1F*X_$4X9JGG@0B;>>DHO$QD53AM$4AJ:$]M&Z"BD4"FS0EZZ=Y)%Q][.
MD9%I#CH,,PX0U*&L@%GO-W$R5_D0#)I( N\B:B)AY"I^<0J@-O-?*>8:"S,,
M_ZT\:C4PM"."GN&[C1)'G#ATY[QU,+_<#^F]3#$+,;)#>\TB2G8](WA))T2%
MEZ613*RY@1<9GD/:WJ%@QX TQ[4";ZYR%Y_XMDOPSZM[&,5_K6^[#$4].\-2
M1#EC;!C8+5W"^A6S%Y8IG]G=7K'RF=WM;^4S]UUPF2P<#%UC :G3#5Q*5D9O
MV3AR_J775&+[1M'@)1C1U"](D3+<91AK8SE(%1Z#9_J1Q@(^-M:MF%L(*52'
M+)KW:D78)_4QI*CK(&^LEHU%"7/3*:GA:[@Q!>E[=+E]_9TW?15.-N7"$^LK
M;K?,N.B+)Y- =L4W.[ $4EZJME]DP*16#A!>":VBWET "!73]'<V M1[91V+
MS>R-#(BI.)\M'K\D\%(+=,XX_WY9%V\+^])[?+=]"ZQ&K<0765%-QF+I ITI
M^5BV-*13B&9KV8Q@#]S<[LFTNBS/N!F#Y!,F)*V32\0K)2^/*HL!#$+JYK#(
MQ7\=.[\:$EUW1 #J?'1BSK8L];#1.1S(3ZGJLZ1417.)+:\ORVI:LO?A?0?4
MB?H2;>,6&^DX1#.M+S)COPFOA&!S00B;G^IY.9_Y1K%V$9'D  RLGGEMD> X
M*([\,*%9<&4UR8GQ5^V-E$*2Z+N7]9 4M!= RB[$\5>I!/R?S23 %!4Y%B\:
M7SBG#C7'E@"; 4BVT7%P6Z&Q]BC4A(T5?S"J^[S$@T3X;=GC<]M/P_$$/4T.
M+!+/+E-VDV.$)5/SV25#G6(K9M$R>W2G+:F+6D6)S;XYX*.#HQBK=JI!COA%
M;<\>V*F+"I>"'*K95ZG=43U5G[8+'K1J:WW61R]HKKB^BQM=@WV]2<\$"DB#
M6Z'U-=N2.B0+T8 H+!C@4M)1KJ1TG _W?"XK'9U&H*LLN9GVZA-W?[_K;_$2
M5RNYQ$3Z^);0ZZTAT]?VUPAFLDAL.K T;$R"X9.9JT^[]B0<XF"A[9_GF88*
MXW<2@H@9F:8P>&$@UV=$"%S/J_)C6&ULA"<<Y/4UU3\.;&=H4O2*5#<5??C)
M#,BGE[AW=(5;YYMDL9CKJF+J%;6\J  DV_SRDHG$^L]&TQGJ Z%2T$(&;UKG
M1*S [*,Q7(DVP6XWT*BJ]B1 @FEK,76F-&BV48LB1_"!T'E\DI4C:VH+OT*4
M3@%>PGE. &J-0\NB+JV4/-NG EE$,+YJ&N!?$@=Z;S- HN.=OR>.KVW]Z01_
MT.5UK)>53YEMI6#A+4"T&B?KZAZKMBS$Q$+5TN*<-TX9*T3#(">0;UU]$M90
MJ+^?*DH$:B9([DJN*A0DF],"'F,NQ[=@.ZSQ*'N:V';]:^9L1V/0 4#AHZ*+
M3I"E9EKV!&Q]F2=UE4*W/&.@3;Y7[]]ODUA?FXL_PV@LF*V'R(^%[__DH0>F
M"M]F?6UXMK[D"*$\9*G<R\ZJY5YVON5>[E/ FNB+]K!! _*[QMYZ;8XX<ZXJ
M3ZI/4(+:B#M0G%("R]4VP)QB^*UI%7GV@65:E:+DJBPP>U!:6G?+'6$;?UO=
M.-JK'(0 IFKJ\YXZ/P3GCO\VUMY#O%SMW*J=^&,QQ(X5A?/!A==*T,LVZ#HS
MK\Z%"JQ4_YN'S%=%EK"\:[$/6 4[.QO)2GK(!/#YZO#-T5XG#RIQ\[ 3RRAS
MJA2/JWW$1P58*VCE:BW,-3RC!RQ$13CNPG/LWJ+E8RA)H,<%[MRHPDT_5.(%
M3<14AJ;;@'1AF@N:8P_"F88 <J I\QJ!?=BKE?:LGFQ1UW>:C4M7)X<)AGWS
M\#H_F5I.Q=6:&>Y%D".G,T6AQC8F/JL06@NNI>##>85P1/48(= Z6HZ.&:%0
MAZ2OY6@<9\">!>3K9E>5^)/0KK/X4Q<G5*+U[HJNUTE=?<BH<3A#OM*\R&VA
M>N<+EII#J^ ]^0HB7R.>+K7'X].AN(%X3O%WL.6+JFE@[D=%DH_!(^#,6PY_
MY.XQ=J*2<0)%?QN*_E+8))#^$K=RK&^O<X34;)]3H!P\CS.N6D"_8WW-/@NB
M-'CT].&M8N[F=0\0:(E)DN,7&J,>N:QC8SZAQY.-$1X\FQ&Q;@E 2[R^UDSS
MEBP+6Q<JD*,J32LR ^A2L."Y+#)"7+$\(00)?XC!9G>;[O=G]MM&O]5F.^,?
M'1XR9#]MXAR7"U/ M9GW3:JNARZO<\+/PAF,?8Q"3WKX/E3K:D05(G 4) 1:
M06OH88"5I741:IP%;N[5.<._4^SF*I)+G](-VQ5'%,#A#]7;&GFMN &?H-N6
M$U>HPV!I36HXQ"#]#,P,-6+5G20-3,X0:@]TB'TD>J]^%5 -8I>=$=_BXII+
MCQ3L4\I_'1=)L&@)*ZNX''1!BSN^)=U3HVGT.(TY[IDR$ZB-D ?J1W B,51$
M'>$^<8C##EYP)\>_TZW@QIJ0E)J\J3#<5=C;B)_KLW%5$$92("3.<6>DA1ZN
MM]F8<86WKMJG579_LU6S/$ZOBKFW[HZ5TRO$PM["I<IHZ4J_  M=J_\CR027
M&@Z,64@E^6KG5-?+8*\VBD1^T6L4C767*!T9;&0U74G6%I@'.FW) !4O!%[.
M@T.4!.L6=%DB!+!8$:H2B)[9][SKW::?V2WO=CQM>$6(^*EFI534(497ZI0%
MSGA0,5A1D7)_VS&%R"1<-&(V?TZ* 78*E+A0@YF *N@=U 7)[-)*]M"Y5?*J
M>WWED5^;>3/OWS O1RXHF%:7.,'NX.H080TJ2$G+>(=J8AE=])([0;+]S0BT
M06U&@BMAUY4QRO4;$?Z97P;T18<;E^G.[*;#ATU:3S*6-FN[" _6JG7&)5NW
M/4PXW)E<D-<YUM;75*>&O9$8&6*67IY7@GC;UE7A#RB,OV2#!H_##8<:R'AW
MVV9TNT8*1J?R1IY<V ,JEXH]MD?X N_0H/1F$,S=XC^)#=Z'<Y]GBT>W98K#
M)I]GBT>W;(JOKPW:XM&MF^)L=ONV>'2=IK@U'GKRHBUP\$*4"1Z0]ENQP$%6
M/!-\22F]9@N<2^4[)OA274_7:H'#JO3[!D"GW)P)&?4M2"QI_203<EDFKW;H
M^&9B;336( M@D[6?8;)=CY5E'+*%9E9T\U:6V3$+S:SH<ZVLDU6,F2^5F-U=
MM<3L[K?$['T77$9_  *T+)W6#*RR!TXY&1O4>5]7T'%.!,%H35";!3H^TMSM
M[)PP-^ 3K&P%'PL@_8R> F5*#"?2RF\4BDO;PKF?E9(AY9PI=X2(C4HQ0ARH
M8TRRC250_8,64-[P*%$Q.P.W;X'-",293+'@>QB3D&J%$&!@)NPL@/@;N!GW
M%JM7L84O8D>:#\QY1$2.HVHR$^"@20)^B;%5ZPLP2,"(UL>X.>\KR7.?S@9'
M8+NSJ<4E"P=C9A24P&R[]G8C:1DB'Q<S?NP1!PQ3YP)C%] \,6!^AL''2>%3
M_V$\7F=Z6D9-,PRI50H>3?A@(H\A%T%*!3HV0LR%20Y0![K&+*2 >=YIEB,7
M%RXELX-=\'YHT )*LU.R-OD@[L_X5G38[W0R(SY!IMW6<\/"\7BRH."OS< S
M<-L@R*82P'A(!"3\8:[)VX)L"MP* !DJIF$:AP)A9BA98>89WY=K[^#&-OC*
MVUI0A'KO$U((V(_E]$%H(\'?>.IL5*UW\SCZEQ&/%@Q"2_1!ODA@$AKCHQ8)
MD&3SW-(+0_<$L\SSTOJ/)S;%)7@AJ?8D,$;TZO#E^95[+Z1&.3B/O-ZX&!*^
MZ@V]+P&R@ZVV.,EP5Q9SEDQ8<\E%M_Z=];,RVYLJ1KVY:U%=4MR%/A3 -!T!
M&%5-R]SO-A2 Y"F*'M=Z_YWMY487(*!1,T U#?UOX?M33ZMWP%&N%*>VNBSM
M,FMG2>1 ]/1IUHN-,'?HN3FK50&DW$RV'T<7^9NXA3WEKG4@ALLV=LC!HT'*
MUI#;#LX0E%50XZZK+<\I7\)86P-2$D<;NYMS;JJ$GTB,8.DW;$(&NAWEA,<A
M;HI?!\4^W U 0F6UJ(/8@] A.9G^%M;Q%;P=^/)I?HK(,BUM)DXSJ="N>?$F
M\^\>WG$QDK,EZ+05.<4S)A4H0 0HL7_./N8@O7/>=G!#;7KDD6&5/Z .-H1U
MP(PD:0;/>+N[Z6C5 D[>;5>_Z:.IER(+O !$&QYM^BI./1^$ QX/(.801N *
MA%1/35C1ZH%P #;1&7SL$0D?'3;6.GQV8-\PAY39<APA+X>OFGA+IWES,JT;
MCF0$]W5X2]M"@L&<F+8^C7W0VK!OTU95:K?) K/5)J[BD!;$A)N*66+ C:J=
M-.H6&SO8H:/SGK$Z&OK:>_DI\KAX(3UJ1H^U\\!JEJ38G$,6"+5+.\H.+PN;
MD($$MT 9.*7@UI#&U--KB^=QS.MKBP8MBUEG^1@O[)T^:CF</8-2-&,B.CJU
MP,$:VI]H*L5RLF!Y8W?*\<AQ$6S?,S*?D\]#3?:<5X80)QQ>#AZ]A-0J4-0'
MC2"0H)C,I8K/,ZIE[=S -KL&#!H:(@[(S$4-YC3_1E\5,[)L:]MJ;[OU^?TM
MLIQ"1P-]09$[]\I*GKLA,V&["_9 ]=R#C<OS#%>]JBGU&_9T@/A23#$*M6[&
M<ARC3+GUB0=>GYGD&-'%HO0BVEF1,1)">&[Q-%M?P\2,=9T@ELW[F6'?9GY\
MFXR-X9G[BE.6*5??=6H0H\,2)(N+.-A*Q2T&MR,[]=_3O,6=-U+?1KWJX87E
MNB?)+A@7LEC[ER*MOM<*2YJ<U<GDO''MA#VY]!G/ SDKQ.W!8E8P0$5-D&:&
M;Y]GA83KIZ5"+%:XF5(ZTW98X_VVJ!#7A/#WT 19,ZJM .'E<W*'!%NX;$Y0
M&9[+I0<Q+1C*"BY3=Q?,L9']3Y:(6?'IB !BRIDO/[9JN@->B<M!Z>@P^Q=7
M8'.( GPKOAARUI(47IRN#J7L;,-I)Y\.=UZ<3J<%'&BZI91Z4B LRJQSG.F)
MV0Q3%X=DCF_$J4BL#F%:[0I0C- X:!1(M^K/0R2@TT(,7CHQL..DS$X)OCV\
M/-SF =;&.0E1;UQF#_-%L'KD9U[K R)]?[HJ0!)^@A:X,^'\67&;\TW61N^$
MLFJIPB3CVQ L@1-OV8";0^\%"%%)[:L%38W7^YY^W]ZH0MTWP>H]"+'1AL1(
M7W[*^$-FMJJN:N8'.[4,AW3&<!E@"5!C"1L/2A<7R24I2'57= '4=K<+Q(E!
MT"<]4<V;(2&%QU.L<D"8C)/+V=C>Z6)? _52T53>30!:$Q"QNMNU(X=Q2!!C
M3Q+C,,:N2_GJ_"B#N$)8%54TS\?2:5DJ<+!UF/:A0M-M9O,2>'>PW$&"?6!6
M74 ]G7>F-SF4(Q"& %6[J5>@.##C+VU%[Y$74.:?9D[M/=NAXD':8K'+N *]
MR_H<_"O0B%DK;$N<3.Z5#WBU!4.HJ4LD]?OY>S"#N0[+99NQ@" /:*4ZT!1
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M'@,<$[PO(P]23<,H\$!)+;'J+XFG@1!;S5]+)1C8"^2+PQOO@K!$K*]I*Q5
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M*(LBM4:J3U WJ'VTS*IIHX$WX&/43$9X"8OSI%+\BZC(ZJ00V$X]:IX=%E2
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M0\)?X(8<_V06(",@@ !:U]E%-2*.M.G)..>N:?2MR^^,]@-"V@N??89'QAC
M^&[")XUZPG@U1G4H2(1N_"J.7E34?&+^^%M2GL/!5SK@6+!MTMS!>&/D+&\F
MD"!RB T,IF017Q6Q' 9<&6/.HQRAUZ;U"$S!)32L,R\AGE6,]VL)-RW7&)A4
M(?X.Q$X"K ,$DG6ZB\'+)5C<Z:GISJXMP,?YU!73PT_6M(4X3/#[JM)HWAR%
MUTSN=&R)2>"IF,:Q#M_\.^? GC+!(-1<(:(9M*\J6 _P%+QATUC+H!&, O[
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M]@_?';Z-H\,W^UMTQB+DWW4.^M/^>%TS-C1++V9/A^9VU\[MHA/T^L=[M9?
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MU\__'U!+ 0(4 Q0    ( .R+CE:U8.T1/0,  /L+   1              "
M 0    !P<G!O+3(P,C,P-#$T+GAS9%!+ 0(4 Q0    ( .R+CE9L\J,:_PH
M &R'   5              "  6P#  !P<G!O+3(P,C,P-#$T7VQA8BYX;6Q0
M2P$"% ,4    " #LBXY6_)&.IU<'  #%6   %0              @ &>#@
M<')P;RTR,#(S,#0Q-%]P<F4N>&UL4$L! A0#%     @ [(N.5E#Y!%A$&@
M5X(  !(              ( !*!8  '1M,C,Q,C8R.60R7SAK+FAT;5!+ 0(4
M Q0    ( .R+CE9)%$\=E:H  "A^ P 5              "  9PP  !T;3(S
G,3(V,CED,E]E>#$M,2YH=&U02P4&      4 !0!( 0  9-L

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
